Quarterly Report • Feb 13, 2025
Quarterly Report
Open in ViewerOpens in native device viewer
KBC Group – Investor Relations Office: [email protected]
KBC Group I Quarterly Report – 1Q2025 I p.1

Summary 3 Financial highlights 4 Overview of results and balance sheet 5 Analysis of the quarter 6 ESG developments, risk statement and economic views 9 Our guidance 11 Consolidated financial statements Consolidated income statement 13
Consolidated statement of comprehensive income 14
Consolidated statement of changes in equity 16
Consolidated cash flow statement 18
Notes to the accounting policies 19
Notes on segment reporting 20
Additional information
Credit risk 36 Solvency 40 Income statement, volumes and ratios per business unit 46 Details of ratios and terms 54
The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
'I Bartel Puelinckx, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of the current year.'
KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 15 May 2025
KBC Group I Quarterly Report – 1Q2025 I p.2
| KBC Group – overview (consolidated, IFRS) | 1Q2025 | 4Q2024 | 1Q2024 |
|---|---|---|---|
| Net result (in millions of EUR) | 546 | 1 116 | 506 |
| Basic earnings per share (in EUR) | 1.32 | 2.75 | 1.18 |
| Breakdown of the net result by business unit (in millions of EUR) | |||
| Belgium | 281 | 487 | 243 |
| Czech Republic | 207 | 238 | 197 |
| International Markets | 135 | 175 | 146 |
| Group Centre | -77 | 215 | -80 |
| Parent shareholders' equity per share (in EUR, end of period) | 58.8 | 56.6 | 54.9 |
'We recorded a net profit of 546 million euros in the first quarter of 2025. Compared to the result of the previous quarter, our total income benefited from several factors, including increased insurance revenues, trading and fair value income and net other income, while net interest income and net fee and commission income were slightly down as a result of seasonality and some positive year-end effects in the fourth quarter of 2024.
Our loan portfolio continued to expand, increasing by 2% quarter-on-quarter and by 7% year-on-year. Customer deposits – excluding volatile, low-margin short-term deposits at KBC Bank's foreign branches – were stable quarter-on-quarter (with a shift from term deposits to savings accounts) and up 7% year-on-year.
Operating expenses were up, since the bulk of the bank and insurance taxes for the full year are recorded – as usual – in the first quarter. Disregarding bank and insurance taxes, operating expenses fell by 8% quarter-on-quarter. Insurance service expenses also fell, as did loan loss impairment charges, resulting in a very favourable credit cost ratio of just 8 basis points for the quarter under review (16 basis points excluding the changes in the reserve for geopolitical and macroeconomic uncertainties).
Our solvency position remained strong, with an unfloored fully loaded common equity ratio under Basel IV of 14.5% at the end of March 2025. Our liquidity position remained very solid too, as illustrated by an LCR of 157% and NSFR of 140%.
On 8 May 2025, we paid a final dividend of 3.15 euros per share, bringing the total dividend for full-year 2024 to 4.85 euros per share. We also updated our dividend and capital deployment policy. As from 2025, we will pay a dividend of between 50% and 65% of our consolidated result, 1 euro of which will be paid in November as an interim dividend. We aim to remain amongst the better capitalised financial institutions in Europe. Each year, when announcing the full-year results, our Board will take a decision – at its discretion - on capital deployment. The focus will predominantly be on further organic growth alongside mergers and acquisitions. We see a 13% unfloored fully loaded common equity ratio as the minimum.
Furthermore, KBC reached an agreement to acquire 98.45% of 365.bank in Slovakia based on a total value for 365.bank of 761 million euros. This investment will allow us to further strengthen our position in the Slovak market while closing the gap with the top three players in the banking sector. 365.bank is a retail-focused bank with subsidiaries in asset management and consumer finance and is very complementary to the business of KBC's existing Slovak subsidiary ČSOB, leading to significant cost, revenue (cross-selling) and funding synergies. KBC will particularly strengthen its reach in retail banking as well as benefit from access to the unique client base and distribution network of 365.bank and its exclusive partnership with Slovak Post. Closure of the deal is subject to regulatory approval and will reduce our unfloored fully loaded common equity ratio by approximately 50 basis points upon closing, which is expected by the end of this year.
Recent weeks have been characterised by unprecedented macro-economic (trade) uncertainty as a result of the US policy on trade tariffs and its repercussions on the financial markets. Nevertheless, we confirm our short-term and long-term financial guidance. Last but not least, I would like to express my sincerest gratitude towards our customers, employees, shareholders and all other stakeholders for their continued trust in our group.'

and ideas within the group
Net interest income slightly decreased by 1% quarter-on-quarter and went up by 4% year-on-year. The net interest margin for the quarter under review amounted to 2.05%, down 3 basis points compared to the previous and year-earlier quarters, respectively. Customer loan volumes were up 2% quarter-on-quarter and 7% year-on-year. Customer deposits, excluding volatile, low-margin short-term deposits at KBC Bank's foreign branches, were stable quarter-on-quarter (with a shift from term deposits to savings accounts) and up 7% year-on-year.
The insurance service result (insurance revenues before reinsurance - insurance service expenses before reinsurance + net result from reinsurance contracts held) amounted to 142 million euros (compared to 125 million euros and 134 million euros in the previous and year-earlier quarters, respectively) and breaks down into 96 million euros for non-life insurance and 45 million euros for life insurance. The non-life insurance combined ratio for the quarter under review amounted to an excellent 86%, compared to 90% for full-year 2024. Non-life insurance sales increased by 8% year-on-year, while life insurance sales were up 39% on the level recorded in the previous quarter and up 32% on their level in the year-earlier quarter.
Net fee and commission income was slightly down (-1%) quarter-on-quarter, due entirely to seasonality and positive year-end effects in the previous quarter. Net fee and commission income was up 12% year-on-year, thanks to higher fees for asset management activities and banking services. Assets under management were down 1% quarter-on-quarter and up 6% year-onyear.
Trading & fair value income and insurance finance income and expense was up 29 million euros and 10 million euros on the figures for the previous and year-earlier quarters, respectively. Net other income was above its normal run rate due mainly to higher-than-average gains on the sale of real estate.
Operating expenses excluding bank and insurance taxes were down 8% quarter-on-quarter and up 4% year-on-year. The first quarter of the year traditionally includes the bulk of the bank and insurance taxes for the full year (539 million euros in the first quarter of 2025). The cost/income ratio for the first quarter of 2025 came to 46%, compared to 47% for full-year 2024. In that calculation, certain non-operating items have been excluded and bank and insurance taxes spread evenly throughout the year. When excluding all bank and insurance taxes, the cost/income ratio for the first quarter of 2025 amounted to 41%, compared to 43% for full-year 2024.
Loan loss impairment charges amounted to 38 million euros, compared to 50 million euros in the previous quarter and 16 million euros in the year-earlier quarter. The credit cost ratio for the quarter under review amounted to 0.08%, compared to 0.10% for fullyear 2024. Impairment on assets other than loans was virtually zero in the quarter under review.
Our liquidity position remained strong, with an LCR of 157% and NSFR of 140%. Our capital base remained robust, with an unfloored fully loaded common equity ratio of 14.5%*.



* For the fully loaded common equity ratio as of the first quarter of 2025, KBC focuses on the so-called unfloored fully loaded common equity ratio, which takes into account the total risk-weighted assets impact of Basel IV, excluding the output floor impact.
| Consolidated income statement, IFRS, | |||||
|---|---|---|---|---|---|
| KBC Group (simplified; in millions of EUR) | 1Q2025 | 4Q2024 | 3Q2024 | 2Q2024 | 1Q2024 |
| Net interest income | 1 421 | 1 433 | 1 394 | 1 379 | 1 369 |
| Insurance revenues before reinsurance Non-life |
773 648 |
764 640 |
740 631 |
726 613 |
714 598 |
| Life | 125 | 124 | 109 | 114 | 116 |
| Dividend income | 9 | 13 | 11 | 26 | 7 |
| Net result from financial instruments at fair value through P&L and Insurance finance income and expense |
-45 | -74 | -42 | 3 | -55 |
| Net fee and commission income | 690 | 700 | 641 | 623 | 614 |
| Net other income | 67 | 27 | 45 | 51 | 58 |
| Total income | 2 915 | 2 863 | 2 787 | 2 809 | 2 708 |
| Operating expenses (excl. directly attributable from insurance) | -1 498 | -1 126 | -1 058 | -950 | -1 431 |
| Total operating expenses excluding bank and insurance taxes | -1 106 | -1 201 | -1 135 | -1 074 | -1 063 |
| Total bank and insurance taxes | -539 | -55 | -47 | -2 | -518 |
| Minus: operating expenses allocated to insurance service expenses | 148 | 131 | 124 | 126 | 150 |
| Insurance service expenses before reinsurance | -622 | -635 | -688 | -590 | -563 |
| Of which Insurance commission paid | -102 | -103 | -99 | -92 | -89 |
| Non-Life | -543 | -561 | -615 | -514 | -489 |
| Life | -79 | -74 | -72 | -76 | -73 |
| Net result from reinsurance contracts held | -9 | -4 | 28 | -24 | -18 |
| Impairment | -38 | -78 | -69 | -85 | -16 |
| Of which: on financial assets at amortised cost and at fair value through other comprehensive income1 |
-38 | -50 | -61 | -72 | -16 |
| Share in results of associated companies & joint ventures | 0 | -1 | 78 | 2 | 0 |
| Result before tax | 747 | 1 020 | 1 079 | 1 162 | 680 |
| Income tax expense | -202 | 96 | -211 | -237 | -175 |
| Result after tax | 546 | 1 115 | 868 | 925 | 506 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 546 | 1 116 | 868 | 925 | 506 |
| Basic earnings per share (EUR) | 1.32 | 2.75 | 2.14 | 2.25 | 1.18 |
| Diluted earnings per share (EUR) | 1.32 | 2.75 | 2.14 | 2.25 | 1.18 |
| Key consolidated balance sheet figures, IFRS, | |||||
| KBC Group (in millions of EUR) | 31-03-2025 | 31-12-2024 | 30-09-2024 | 30-06-2024 | 31-03-2024 |
| Total assets | 380 313 | 373 048 | 353 261 | 361 945 | 359 477 |
| Loans & advances to customers | 197 326 | 192 067 | 188 623 | 187 502 | 183 722 |
| Securities (equity and debt instruments) | 84 419 | 80 339 | 75 929 | 73 941 | 73 561 |
| Deposits from customers | 231 022 | 228 747 | 221 851 | 221 844 | 216 314 |
| Insurance contract liabilities | 16 912 | 17 111 | 17 012 | 16 521 | 16 602 |
| Liabilities under investment contracts, insurance | 15 631 | 15 671 | 15 193 | 14 780 | 14 319 |
| Total equity | 25 191 | 24 311 | 23 300 | 22 936 | 23 917 |
| Selected ratios KBC Group (consolidated) | 1Q2025 | FY2024 | |||
| Return on equity2 | 9% | 15% | |||
| Cost/income ratio, group | |||||
| - excl. non-operating items and evenly spreading bank and insurance taxes throughout the year |
46% 41% |
47% 43% |
|||
| - excl. all bank and insurance taxes | |||||
| Combined ratio, non-life insurance | 86% | 90% | |||
| Common equity ratio (CET1), fully loaded (Basel IV as of 2025, Danish Compromise, unfloored3) | 14.5% | 15.0% | |||
| Credit cost ratio4 | 0.08% | 0.10% | |||
| Impaired loans ratio | 1.9% | 2.0% | |||
| for loans more than 90 days past due | 1.0% | 1.0% | |||
| Net stable funding ratio (NSFR) | 140% | 139% | |||
| 158% |
1 Also referred to as 'Loan loss impairment'.
2 15% for the first quarter of 2025 (and 14% for full-year 2024), when non-operating items are excluded and bank and insurance taxes spread evenly throughout the year.
3 For the fully loaded common equity ratio as of the first quarter of 2025, KBC focuses on the so-called unfloored fully loaded common equity ratio, which takes into account the total risk-weighted
assets impact of Basel IV, excluding the output floor impact.. 4 A negative figure indicates a net impairment release (positively affecting results).
Net interest income amounted to 1 421 million euros in the quarter under review, slightly down by 1% quarter-on-quarter and up 4% year-on-year.
The quarter-on-quarter change was due to factors such as the positive impact of a higher commercial transformation result, higher lending income (as the positive impact of loan volume growth was only partly offset by the negative impact of pressure on loan margins in some core markets) and higher dealing room interest income. These items were more than offset by the negative impact of the lower number of days in the quarter under review, lower net interest income on inflation-linked bonds, a lower level of interest income from customer term deposits and from short-term cash management activities, higher costs related to the minimum required reserves held with central banks, and the fact that the previous quarter had benefited from a positive correction of 9 million euros arising from a change in the accounting approach to mortgage brokerage fees in Bulgaria (the impact for full-year 2024 was recorded entirely in the fourth quarter). The year-on-year increase was due to a combination of a significantly higher commercial transformation result, higher lending income, lower costs related to the minimum required reserves held with central banks, higher net interest income on inflation-linked bonds and higher dealing room interest income. These items were partly offset by a lower level of interest income from customer term deposits, higher wholesale funding costs and a lower level of interest income from shortterm cash management activities.
The net interest margin for the quarter under review amounted to 2.05%, down 3 basis points quarter-on-quarter and year-on-year. Customer loan volume (197 billion euros) was up 2% quarter-on-quarter and 7% year-on-year. Customer deposits (231 billion euros) were stable quarter-on-quarter (with a shift from term deposits to savings accounts) and up 6% year-on-year. When excluding volatile, low-margin short-term deposits at KBC Bank's foreign branches (driven by short-term cash management opportunities), customer deposits were also stable quarter-on-quarter and up 7% year-on-year. The growth figures above exclude the forex-related impact.
For guidance regarding expected net interest income in 2025 and the years to come, please refer to the section entitled 'Our guidance'.
The insurance service result (insurance revenues before reinsurance – insurance service expenses before reinsurance + net result from reinsurance contracts held; the two latter items are not part of total income) amounted to 142 million euros and breaks down into 96 million euros for non-life insurance and 45 million euros for life insurance.
The non-life insurance service result rose by 27% quarter-on-quarter, thanks to lower insurance service expenses coupled with higher insurance revenues, and only partly offset by a worse reinsurance result. It was up 3% year-on-year as higher insurance revenues and a better reinsurance result were for a large part offset by increased insurance service expenses.
The life insurance service result was down 8% quarter-on-quarter, essentially due to higher insurance service expenses. It was up 12% year-on-year, as increased insurance revenues and a better reinsurance result more than offset the higher insurance service expenses.
The combined ratio of the non-life insurance activities amounted to an excellent 86% for the quarter under review, compared to 90% for full-year 2024. Non-life insurance sales came to 792 million euros and were up 8% year-on-year, with growth in all countries and all the main classes. Sales of life insurance products amounted to 1 013 million euros and were up 39% on the level recorded in the previous quarter, thanks to a large increase in unit-linked insurance sales in Belgium (supported by structured issues), and up 32% on the level recorded in the year-earlier quarter (higher sales of unit-linked, interest-guaranteed and hybrid products). Overall, the share of guaranteed-interest products and unit-linked products in our life insurance sales in the quarter under review amounted to 33% and 61%, respectively, with hybrid products (mainly in Belgium and the Czech Republic) accounting for the remainder.
For guidance regarding expected insurance revenues and the combined ratio in 2025 and the years to come, please refer to the section entitled 'Our guidance'.
Net fee and commission income amounted to 690 million euros, down 1% quarter-on-quarter and up 12% year-on-year. The slight quarter-on-quarter decrease was due entirely to seasonality and positive year-end effects in the previous quarter, while the significant year-on-year increase was thanks to higher fees for asset management activities (mainly increased management fees) and for various banking services (mainly payment services and network income).
At the end of March 2025, our total assets under management amounted to 273 billion euros, down 1% quarter-on-quarter as the negative market performance in the quarter (-3 percentage points) more than offset the positive impact of net inflows (+2 percentage points). Assets under management still grew by 6% year-on-year, with net inflows accounting for 3 percentage points and the positive market performance during the year accounting for the other 3 percentage points.
Trading & fair value income and insurance finance income and expense amounted to -45 million euros, up 29 million euros quarter-on-quarter and 10 million euros year-on-year. Quarter-on-quarter, the improvement was mainly thanks to a positive evolution of the market value of derivatives used for asset/liability management purposes and a higher dealing room result, whereas year-onyear, the improvement was mainly thanks to a positive evolution of the market value of derivatives used for asset/liability management purposes, partly offset by lower dealing room results.
The other remaining income items included dividend income of 9 million euros and net other income of 67 million euros. The latter was above its (50-million-euro) normal run rate, due mainly to higher-than-average gains on the sale of real estate.
Operating expenses excluding bank and insurance taxes amounted to 1 106 million euros in the first quarter of 2025, down 8% on their level in the previous quarter and up 4% year-on-year*.
The quarter-on-quarter decrease was due mainly to seasonally lower expenses for marketing and professional fees, decreased ICT costs and lower facilities costs, partly offset by higher staff costs. The year-on-year increase of operating expenses excluding bank and insurance taxes was mainly caused by higher staff costs (wage drift and indexation, partly offset by fewer FTEs), ICT expenses and depreciation charges.
Bank and insurance taxes in the quarter under review amounted to 539 million euros, compared to 55 million euros in the previous quarter, as the bulk of the bank and insurance taxes for the full year is traditionally recorded in the first quarter of the year. Year-onyear, bank and insurance taxes were up 4%, owing partly to a higher contribution to the deposit guarantee scheme in Belgium (due to factors such as a higher covered deposit volume), which more than offset the lower contribution to the resolution fund in the Czech Republic and lower (national) bank taxes in Slovakia and Hungary.
When certain non-operating items are excluded and bank and insurance taxes are spread evenly throughout the year, the cost/income ratio for the quarter under review amounted to 46%, compared to 47% for full-year 2024. When excluding all bank and insurance taxes, the cost-income ratio amounted to 41%, compared to 43% in full-year 2024.
For guidance regarding expected operating expenses in 2025 and the years to come, please refer to the section entitled 'Our guidance'.
* Note that operating expenses excluding bank and insurance taxes were low in the first half of 2024, hence we feel comfortable with our full year 2025 guidance of growth for operating expenses excluding bank and insurance taxes of below 2.5% year-on-year.
versus a 50-million-euro net charge in the previous quarter and a 16-million-euro net charge in the year-earlier quarter
In the quarter under review, we recorded a 38-million-euro net loan loss impairment charge, compared to a net charge of 50 million euros in the previous quarter and a net charge of 16 million euros in the year-earlier quarter. The net impairment charge in the quarter under review included a charge of 83 million euros in respect of our loan book (41 million euros of which related to lowering the backstop shortfall for old non-performing loans in Belgium) and a model-driven release of 45 million euros following the update of the reserve for geopolitical and macroeconomic uncertainties. As a consequence, the outstanding reserve for geopolitical and macroeconomic uncertainties amounted to 72 million euros at the end of March 2025.
The resulting credit cost ratio amounted to 0.08% for the quarter under review (0.16% excluding the changes in the reserve for geopolitical and macroeconomic uncertainties), compared to 0.10% for full-year 2024 (0.16% excluding the changes in the reserve for geopolitical and macroeconomic uncertainties). At the end of March 2025, 1.9% of our total loan book was classified as impaired ('Stage 3'), compared to 2.0% at year-end 2024. Impaired loans that are more than 90 days past due amounted to 1.0% of the loan book, the same as at year-end 2024.
For guidance regarding the expected credit cost ratio in 2025 and the years to come, please refer to the section entitled 'Our guidance'.
Impairment charges on assets other than loans were negligible in the quarter under review, compared to 28 million euros in the previous quarter and also negligible in the year-earlier quarter.
Belgium 281 million euros; Czech Rep. 207 million euros; International Markets 135 million euros; Group Centre -77 million euros
Belgium: the net result (281 million euros) was, at first sight, down 42% on the result for the previous quarter. However, when excluding the bank and insurance taxes (the bulk of the amount for the full year being recorded in the first quarter and hence distorting the quarter-on-quarter comparison), the net result was up 23% quarter-on-quarter. This was due to the combined effect of:
• higher total income (accounted for mainly by higher trading & fair value income, net fee and commission income and other income, and partly offset by lower net interest income and dividend income);
Czech Republic: the net result (207 million euros) was, at first sight, down 13% on the result of the previous quarter. However, when excluding the bank and insurance taxes, the net result was down only 5% quarter-on-quarter. This was due to the combined effect of:
International Markets: the 135-million-euro net result breaks down as follows: 34 million euros in Slovakia, 35 million euros in Hungary and 66 million euros in Bulgaria. For the business unit as a whole, the net result was, at first glance, down 23% on the previous quarter's result. However, when excluding the bank and insurance taxes, the net result was up 24% quarter-on-quarter. This was due to the combined effect of:
Group Centre: the net result (-77 million euros) was 292 million euros lower than the figure recorded in the previous quarter, largely due to much higher income taxes as the previous quarter had included a 318-million-euro one-off tax benefit due to the liquidation of Exicon (the remaining activities of KBC Bank Ireland).
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
| Belgium | Czech Republic | International Markets | ||||
|---|---|---|---|---|---|---|
| Selected ratios by business unit | 1Q2025 | FY2024 | 1Q2025 | FY2024 | 1Q2025 | FY2024 |
| Cost/income ratio | ||||||
| - excl. non-operating items and evenly spreading bank and insurance taxes |
||||||
| throughout the year | 43% | 44% | 43% | 45% | 46% | 46% |
| - excl. all bank and insurance taxes |
39% | 41% | 42% | 43% | 37% | 38% |
| Combined ratio, non-life insurance | 86% | 88% | 81% | 86% | 95%2 | 96%2 |
| Credit cost ratio1 | 0.07% | 0.19% | 0.13% | -0.09% | 0.05% | -0.08% |
| Impaired loans ratio | 1.9% | 2.0% | 1.3% | 1.3% | 1.6% | 1.6% |
1 A negative figure indicates a net impairment release (positively affecting results). See 'Details of ratios and terms' in the quarterly report. 2 Excluding windfall insurance taxes in Hungary, the combined ratio amounted to 93% for full-year 2024 and 87% for the first quarter of 2025.
Common equity ratio of 14.5%, NSFR of 140%, LCR of 157%
At the end of March 2025, total equity came to 25.2 billion euros and comprised 23.3 billion euros in parent shareholders' equity and 1.9 billion euros in additional tier-1 instruments. Total equity was up 0.9 billion euros on its level at the end of 2024. This was due to the combined effect of:
We have provided details of these changes under 'Consolidated statement of changes in equity' in the 'Consolidated financial statements' section of the quarterly report.
In the first quarter of 2025, risk-weighted assets rose by 4.8 billion euros quarter-on-quarter to 124.8 billion euros, mainly driven by the application of Basel IV (see below) and volume growth.
Our solvency position remained strong, as illustrated by an unfloored fully loaded common equity ratio (CET1) of 14.5% under Basel IV at 31 March 2025, compared to 15.0% under Basel III at the end of 2024 (corresponding to 14.6% under Basel IV). The solvency ratio for KBC Insurance under the Solvency II framework was 210% at the end of March 2025, compared to 200% at the end of 2024. We have provided more details on solvency under 'Solvency' in the 'Additional information' section of the quarterly report.
The Annual General Meeting of Shareholders of 30 April 2025 approved a total gross dividend of 4.85 euros per share for financial year 2024, with an interim dividend of 1.0 euro and an extraordinary dividend of 0.70 euros paid in 2024 and the remaining 3.15 euros per share paid on 8 May 2025. The updated dividend policy and capital deployment policy is explained in the 'Our guidance' chapter of this report.
Our liquidity position also remained excellent, as reflected in an LCR ratio of 157% and an NSFR ratio of 140%, compared to 158% and 139%, respectively, at the end of 2024, all well above the regulatory minima of 100%.
KBC, in partnership with its customers, employees and other stakeholders, continues to take important steps in the sustainability journey it embarked upon years ago.
We transparently and consistently share sustainability information, and as of this year we do so in both a dedicated Sustainability Statement in our Annual Report as well as our voluntary Sustainability Report, both available at www.kbc.com.
We are proud that the progress made continues to be recognised by internationally renowned sustainability organisations and rating agencies such as CDP, Sustainalytics, MSCI and S&P Dow Jones Indices.

As we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. KBC closely monitors and manages each of these risks within a strict risk framework, but they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of factors are considered to constitute the main challenges for the financial sector. These stem primarily from geopolitical risks which have increased significantly over the past few years (including the war in Ukraine, conflicts in the Middle East and trade wars as a consequence of US tariff policies). These risks result or may result in shocks for the global economic system (e.g., GDP and inflation) and the financial markets (including interest rates). European economies, including KBC's home markets, are affected too, creating an uncertain business environment, including for financial institutions. Regulatory and compliance
risks (in relation to capital requirements, anti-money laundering regulations, GDPR and ESG/sustainability) also remain a dominant theme for the sector, as does enhanced consumer protection. Digitalisation (with technology, including AI, as a catalyst) presents both opportunities and threats to the business model of traditional financial institutions, while climate and environmental-related risks are becoming increasingly prevalent. Cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole. The war in Ukraine and geopolitical tensions in general have triggered an increase in attacks worldwide. Finally, we have seen governments across Europe taking additional measures to support their budgets (via increased tax contributions from the financial sector) and their citizens and corporate sector (by, for instance, implementing interest rate caps on loans or by pushing for higher rates on savings accounts).
We provide risk management data in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.
US economic activity fell by 0.1% (non-annualised) in the first quarter of 2025, compared to positive growth of 0.6% in the final quarter of 2024. The decline was mainly due to a large rise in imports as companies anticipated the expected increase in import tariffs. As a result of recent US economic policy, specifically with respect to import tariffs, growth in the US is expected to remain subdued, and possibly even negative, in the next few quarters.
Euro area growth in the first quarter amounted to 0.4%, after 0.2% in the fourth quarter of 2024. Export growth strengthened ahead of the tariff announcement. The manufacturing sector shows tentative signs of bottoming out, but the expected recovery in the service sector has not (yet) materialised. Uncertainty around economic policy and the ongoing trade conflict are likely to lead to low economic growth in the euro area over the next quarters. The medium-term growth outlook improves on the back of expected defence spending and infrastructure investments.
Quarter-on-quarter growth in Belgium was 0.4% in the first quarter, implying a strengthening of growth dynamics compared to the previous quarter. Relatively strong domestic demand continued to outweigh the negative contribution to growth from net exports. For the next few quarters, we expect growth to remain broadly in line with that of the euro area.
The Czech economy grew by 0.5% in the first quarter, after 0.7% in the fourth quarter of 2024. This was supported by private consumption against the background of a weak and delayed industrial recovery. Hungarian economic activity shrank by 0.2% in the first quarter due to an industry slump. According to our estimates, first quarter growth in Bulgaria and Slovakia was still relatively resilient at 0.4% and 0.3%, respectively.
The main risk to our short-term outlook for European growth is a further escalation of the ongoing global trade conflict. More specifically, uncertainty is being caused by the prospect of further US policy actions, the EU's response to this and to the potential trade diversion of Chinese export goods away from the US market towards the EU.
In the euro area, inflation remained unchanged at 2.2% in April, driven by the negative demand shock caused by trade tariffs imposed by the US, lower energy prices and the strength of the euro exchange rate. This disinflationary pressure is likely to persist in the coming months. In the US, inflation was 2.4% in March and is likely to increase in the course of 2025 as a consequence of the import tariffs imposed by the government there.
The ECB continued its easing cycle and cut its deposit rate in January, March and April 2025 to its current level of 2.25%. The ECB is expected to cut its policy rate further.
The Fed put its easing cycle on pause in the first quarter amidst economic uncertainty. While the Fed has downgraded its growth outlook due to the trade tariffs imposed, it upgraded its inflation outlook due to the inflationary impact that these tariffs are likely to have. On balance, the Fed is now expected to maintain its pause in the second quarter. If its assessment of the impact of US economic policies allows, the Fed will resume its cautious easing path in the second half of 2025.
There has been a disconnect between the 10-year bond yields in the US and Germany since the start of the first quarter. This was mainly driven by two events. First, a huge fiscal spending plan was passed in the German parliament covering defence spending and infrastructure investment. Increased defence spending plans were also announced at EU level. As a result of the changed German fiscal stance, German 10-year bond yields temporarily rose sharply in early March (before subsequently moderating again). This rise lowered the US-German 10-year spread to about 140 basis points, coming from well over 200 basis points at the beginning of the first quarter. Following this, the announcement of so-called reciprocal tariffs by the US on 2 April led to a sharp rise in US 10 year bond yields, increasing the US-German spread again to about 180 basis points in mid-May. The rise of US bond yields was initially driven by higher inflation expectations and the markets' expectation of future Fed monetary policy. In a second phase, the rise also gradually started to reflect a more general risk aversion towards US assets. This was reflected in the sharp depreciation of the US dollar in April.
The Czech National Bank cut its policy rate in February and May 2025 by 25 basis points each to the current level of 3.50%. The Czech National Bank is expected to moderately cut its policy rate further. Since the beginning of the first quarter, the Czech koruna has appreciated moderately overall due to the weak US dollar and lower energy prices. The koruna is expected to broadly remain stable in the coming quarters.
The Hungarian central bank kept its policy rate unchanged at 6.5% during the first quarter and it is expected to maintain its pause during the second quarter as well. The forint strengthened against the euro for most of the first quarter. However, after the announcement of the reciprocal US tariffs on 2 April, the forint started to depreciate against the euro.
Moving towards the Basel IV era and assuming a static balance sheet and all other parameters ceteris paribus, without mitigating actions, KBC:
resulting in a fully loaded impact of +5.1 billion euros in risk-weighted assets (+8.5 billion euros previously).
| Agenda | 2Q2025 results: 7 August 2025 3Q2025 results: 13 November 2025 |
|---|---|
| Other events: www.kbc.com / Investor Relations / Financial calendar | |
| More information on the quarter under review |
Quarterly report: www.kbc.com / Investor Relations / Reports Company presentation: www.kbc.com / Investor Relations / Presentations |
Condensed interim consolidated financial statements according to IFRS
AC: Amortised Cost ALM: Asset Liability Management AT1: Additional tier-1 instruments BBA: Building block approach CSM: Contractual service margin ECL: Expected Credit Loss FV: Fair Value FVO: Fair Value Option (designated upon initial recognition at Fair Value through Profit or Loss) FVOCI: Fair Value through Other Comprehensive Income FVPL: Fair Value through Profit or Loss GCA: Gross Carrying Amount HFT: Held For Trading IFIE: Insurance finance income and expense MFVPL: Mandatorily Measured at Fair Value through Profit or Loss (including HFT) OCI: Other Comprehensive Income OPEX: Operating expenses P&L: Income statement PAA: Premium allocation approach POCI: Purchased or Originated Credit Impaired Assets SPPI: Solely payments of principal and interest SRB: Single Resolution Board R/E: Retained Earnings UL: Unit linked VFA: Variable fee approach
| (in millions of EUR) | Note | 1Q 2025 | 4Q 2024 | 1Q 2024 |
|---|---|---|---|---|
| Net interest income | 3.1 | 1 421 | 1 433 | 1 369 |
| Interest income | 3.1 | 4 421 | 4 620 | 5 123 |
| Interest expense | 3.1 | -3 000 | -3 187 | -3 754 |
| Insurance revenues before reinsurance | 3.6 | 773 | 764 | 714 |
| Non-life | 3.6 | 648 | 640 | 598 |
| Life | 3.6 | 125 | 124 | 116 |
| Dividend income | 9 | 13 | 7 | |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
3.3 | - 45 | - 74 | - 55 |
| Net result from financial instruments at fair value through profit or loss |
3.3 | 12 | 9 | 40 |
| Insurance finance income and expense (for insurance contracts issued) |
3.6 | - 57 | - 83 | - 95 |
| Net fee and commission income | 3.4 | 690 | 700 | 614 |
| Fee and commission income | 3.4 | 854 | 875 | 774 |
| Fee and commission expense | 3.4 | - 164 | - 175 | - 160 |
| Net other income | 3.5 | 67 | 27 | 58 |
| TOTAL INCOME | 2 915 | 2 863 | 2 708 | |
| Operating expenses (excluding opex allocated to insurance expenses) |
3.7 | -1 498 | -1 126 | -1 431 |
| Total Opex without bank and insurance tax | 3.7 | -1 106 | -1 201 | -1 063 |
| Total bank and insurance tax | 3.7 | - 539 | - 55 | - 518 |
| Minus: Opex allocated to insurance service expenses | 3.7 | 148 | 131 | 150 |
| Insurance service expenses before reinsurance | 3.6 | - 622 | - 635 | - 563 |
| Of which insurance commissions paid | 3.6 | - 102 | - 103 | - 89 |
| Non-life | 3.6 | - 543 | - 561 | - 489 |
| Of which Non-life - Claim related expenses | 3.6 | - 337 | - 364 | - 293 |
| Life | 3.6 | - 79 | - 74 | - 73 |
| Net result from reinsurance contracts held | 3.6 | - 9 | - 4 | - 18 |
| Impairment | 3.9 | - 38 | - 78 | - 16 |
| on FA at amortised cost and at FVOCI | 3.9 | - 38 | - 50 | - 16 |
| on goodwill | 3.9 | 0 | 0 | 0 |
| other | 3.9 | 0 | - 28 | 0 |
| Share in results of associated companies and joint ventures | 3.10 | 0 | - 1 | 0 |
| RESULT BEFORE TAX | 747 | 1 020 | 680 | |
| Income tax expense | 3.11 | - 202 | 96 | - 175 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | |
| RESULT AFTER TAX | 546 | 1 115 | 506 | |
| attributable to minority interests | 0 | 0 | 0 | |
| attributable to equity holders of the parent | 546 | 1 116 | 506 | |
| Earnings per share (in EUR) | ||||
| Ordinary | 1.32 | 2.75 | 1.18 | |
| Diluted | 1.32 | 2.75 | 1.18 |
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 1Q 2024 |
|---|---|---|---|
| RESULT AFTER TAX | 546 | 1 115 | 506 |
| Attributable to minority interests | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 546 | 1 116 | 506 |
| OCI THAT MAY BE RECYCLED TO PROFIT OR LOSS | 451 | - 164 | - 153 |
| Net change in revaluation reserve (FVOCI debt instruments) | - 111 | - 122 | - 99 |
| Net change in hedging reserve (cashflow hedges) | 224 | - 27 | 4 |
| Net change in translation differences | 70 | - 33 | - 168 |
| Hedge of net investments in foreign operations | - 11 | - 9 | 41 |
| Net insurance finance income and expense from (re)insurance contracts issued and held |
284 | 27 | 67 |
| Net change in respect of associated companies and joint ventures | 0 | 0 | 0 |
| Other movements | - 5 | - 1 | 2 |
| OCI THAT WILL NOT BE RECYCLED TO PROFIT OR LOSS | - 76 | 51 | 152 |
| Net change in revaluation reserve (FVOCI equity instruments) | - 50 | 40 | 115 |
| Net change in defined benefit plans | - 26 | 11 | 37 |
| Net change in own credit risk | 0 | 0 | 0 |
| Net change in respect of associated companies and joint ventures | 0 | 0 | 0 |
| TOTAL COMPREHENSIVE INCOME | 921 | 1 003 | 505 |
| Attributable to minority interests | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 921 | 1 003 | 505 |
The largest movements in other comprehensive income (1Q 2025 and 1Q 2024):
| (in millions of EUR) | Note | 31-03-2025 | 31-12-2024 |
|---|---|---|---|
| ASSETS | |||
| Cash, cash balances with central banks and other demand deposits with credit institutions | 29 617 | 46 834 | |
| Financial assets | 4.0 | 343 335 | 318 540 |
| Amortised cost | 4.0 | 290 395 | 265 875 |
| Fair value through OCI | 4.0 | 25 130 | 24 261 |
| Fair value through profit or loss | 4.0 | 27 543 | 28 132 |
| of which held for trading | 4.0 | 9 915 | 10 509 |
| Hedging derivatives | 4.0 | 267 | 271 |
| Reinsurers' contract assets held | 105 | 119 | |
| Profit/loss on positions in portfolios hedged for interest rate risk | -2 264 | -1 930 | |
| Tax assets | 937 | 1 002 | |
| Current tax assets | 51 | 59 | |
| Deferred tax assets | 886 | 942 | |
| Non-current assets held for sale and disposal groups | 1 | 1 | |
| Investments in associated companies and joint ventures | 116 | 116 | |
| Property, equipment and investment property | 4 003 | 3 981 | |
| Goodwill and other intangible assets | 2 513 | 2 475 | |
| Other assets | 1 951 | 1 911 | |
| TOTAL ASSETS | 380 313 | 373 048 | |
| LIABILITIES AND EQUITY | |||
| Financial liabilities | 4.0 | 334 634 | 328 723 |
| Amortised cost | 4.0 | 312 064 | 306 050 |
| Fair value through profit or loss | 4.0 | 22 285 | 22 356 |
| of which held for trading | 4.0 | 5 674 | 5 677 |
| Hedging derivatives | 4.0 | 286 | 316 |
| Insurance contract liabilities | 5.6 | 16 912 | 17 111 |
| Non-life | 5.6 | 3 247 | 3 186 |
| Life | 5.6 | 13 665 | 13 925 |
| Profit/loss on positions in portfolios hedged for interest rate risk | - 354 | - 386 | |
| Tax liabilities | 645 | 470 | |
| Current tax liabilities | 216 | 121 | |
| Deferred tax liabilities | 429 | 349 | |
| Liabilities associated with disposal groups | 0 | 0 | |
| Provisions for risks and charges | 139 | 141 | |
| Other liabilities | 3 144 | 2 678 | |
| TOTAL LIABILITIES | 355 122 | 348 737 | |
| Total equity | 5.10 | 25 191 | 24 311 |
| Parent shareholders' equity | 5.10 | 23 327 | 22 447 |
| Additional tier-1 instruments included in equity | 5.10 | 1 864 | 1 864 |
| Minority interests | 0 | 0 | |
| TOTAL LIABILITIES AND EQUITY | 380 313 | 373 048 |
The increase of the total liabilities in 1Q 2025 can for the largest part be explained by higher customer deposits and higher repos.
The total assets increase in 1Q 2025 can for the largest part be explained by higher loans and advances to customers, increased bond portfolio and higher reverse repos, partly offset by lower cash and cash balances with central banks.
| Issued and |
AT1 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| paid up | Total | Parent | instruments | ||||||
| (in millions of EUR) | share capital |
Share premium |
Treasury shares |
Retained earnings |
revaluation reserves |
shareholders' equity |
included in equity |
Minority interests |
Total equity |
| 31-03-2025 | |||||||||
| Balance at the beginning of the period | 1 462 | 5 564 | - 1 300 | 15 724 | 997 | 22 447 | 1 864 | 0 | 24 311 |
| Net result for the period | 0 | 0 | 0 | 546 | 0 | 546 | 0 | 0 | 546 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 5 | 380 | 375 | 0 | 0 | 375 |
| Subtotal | 0 | 0 | 0 | 541 | 380 | 921 | 0 | 0 | 921 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coupon on AT1 | 0 | 0 | 0 | - 40 | 0 | - 40 | 0 | 0 | - 40 |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital increase | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 | 14 | - 14 | 0 | 0 | 0 | 0 |
| Purchase/sale of treasury shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in minorities interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total change | 0 | 0 | 0 | 515 | 366 | 881 | 0 | 0 | 880 |
| Balance at the end of the period | 1 462 | 5 564 | - 1 300 | 16 238 | 1 363 | 23 327 | 1 864 | 0 | 25 191 |
| 2024 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 548 | - 497 | 14 332 | 1 166 | 22 010 | 2 250 | 0 | 24 260 |
| Restatement related to previous year(s) | 0 | 0 | 0 | - 41 | 0 | - 41 | 0 | 0 | - 41 |
| Restated balance at the beginning of the period |
1 461 | 5 548 | - 497 | 14 290 | 1 166 | 21 968 | 2 250 | 0 | 24 219 |
| Net result for the period | 0 | 0 | 0 | 3 415 | 0 | 3 415 | 0 | - 1 | 3 414 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 2 | - 121 | - 123 | 0 | 0 | - 123 |
| Subtotal | 0 | 0 | 0 | 3 413 | - 121 | 3 292 | 0 | - 1 | 3 292 |
| Dividends | 0 | 0 | 0 | - 1 942 | 0 | - 1 942 | 0 | 0 | - 1 942 |
| Coupon on AT1 | 0 | 0 | 0 | - 84 | 0 | - 84 | 0 | 0 | - 84 |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | - 2 | 0 | - 2 | - 386 | 0 | - 388 |
| Capital increase | 1 | 16 | 0 | 0 | 0 | 17 | 0 | 0 | 17 |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 | 47 | - 47 | 0 | 0 | 0 | 0 |
| Purchase/sale of treasury shares | 0 | 0 | - 803 | 0 | 0 | - 803 | 0 | 0 | - 803 |
| Change in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in minorities interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Total change | 1 | 16 | - 803 | 1 433 | - 168 | 478 | - 386 | 0 | 93 |
| Balance at the end of the period | 1 462 | 5 564 | - 1 300 | 15 724 | 997 | 22 447 | 1 864 | 0 | 24 311 |
| 31-03-2024 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 548 | - 497 | 14 332 | 1 166 | 22 010 | 2 250 | 0 | 24 260 |
| Net result for the period | 0 | 0 | 0 506 |
0 | 506 | 0 | 0 | 506 | |
| OCI for the period | 0 | 0 | 0 2 |
- 3 | - 1 | 0 | 0 | - 1 | |
| Subtotal | 0 | 0 | 0 508 |
- 3 | 505 | 0 | 0 | 505 | |
| Dividends | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Coupon on AT1 | 0 | 0 | 0 - 31 |
0 | - 31 | 0 | 0 | - 31 | |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 0 |
0 | 0 | - 500 | 0 | - 500 | |
| Capital increase | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 3 |
- 3 | 0 | 0 | 0 | 0 | |
| Purchase/sale of treasury shares | 0 | 0 - 317 |
0 | 0 | - 317 | 0 | 0 | - 317 | |
| Change in scope | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Change in minorities interests | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Total change | 0 | 0 - 317 |
480 | - 7 | 157 | - 500 | 0 | - 343 | |
| Balance at the end of the period | 1 461 | 5 548 | - 814 | 14 812 | 1 159 | 22 166 | 1 750 | 0 | 23 917 |
The Annual General Meeting on 30 April 2025 approved a final gross dividend of 4.85 euros per share related to the accounting year 2024, of which:
The 'Dividends' item in 2024 (1 942 million euros) includes the final dividend 2023 of 3.15 euros per share, the distribution of the surplus capital above the fully loaded CET1 ratio of 15% in the form of an extraordinary interim dividend of 0.70 euros per share on 29 May 2024 and the interim dividend of 1.00 euro per share (paid in November 2024)
Restatement related to previous year(s): adjustment of tax calculation in the Czech Republic. Given the relatively limited impact, the balance sheet and income statement for 2023 were not retroactively restated.
Issue/repurchase of AT1 included in equity: on 5 March 2024, KBC Group NV called the Additional Tier-1 Securities (AT1) issued in 2019 for 500 million euros. On 17 September 2024, KBC Group NV issued 750 million euros in AT1 Securities. On 18 September 2024, KBC Group NV announced the repurchase of part of the AT1 Securities issued in 2018 via a cash tender offer for an aggregate principal amount of 636 million euros.
Treasury shares: within the framework of the share buyback programme of 1.3 billion euros announced on 10 August 2023, the total number of own shares repurchased by KBC during to the programme amounted to 20 980 823 at 31 July 2024, completion date of the share buyback programme.
For more information: https://www.kbc.com/en/share-buy-back and Solvency section further in this report.
| Composition of the 'Total revaluation reserves' column in the previous table (in millions of EUR) | 31-03-2025 | 31-12-2024 | 31-03-2024 |
|---|---|---|---|
| Total | 1 363 | 997 | 1 159 |
| Revaluation reserve (FVOCI debt instruments) | - 795 | - 684 | - 696 |
| Revaluation reserve (FVOCI equity instruments) | 289 | 353 | 333 |
| Hedging reserve (cashflow hedges) | - 283 | - 507 | - 575 |
| Translation differences | - 398 | - 468 | - 409 |
| Hedge of net investments in foreign operations | 157 | 169 | 168 |
| Remeasurement of defined benefit plans | 476 | 503 | 471 |
| Own credit risk through OCI | 0 | 0 | 0 |
| Insurance finance income and expense through OCI after reinsurance | 1 916 | 1 633 | 1 866 |
| OPERATING ACTIVITIES Cons. income Result before tax stat. 747 680 Adjustments for non-cash items in profit & loss 191 949 Changes in operating assets (excluding cash and cash equivalents) -5 162 -4 991 Changes in operating liabilities (excluding cash and cash equivalents) 5 465 14 756 Income taxes paid - 69 - 136 Net cash from or used in operating activities 1 172 11 258 INVESTING ACTIVITIES Purchase and proceeds of debt securities at amortised cost 4.1 -3 164 1 796 Acquisition of a subsidiary or a business unit, net of cash acquired (including increases in percentage interest held) 0 0 Proceeds from the disposal of a subsidiary or business unit, net of cash disposed of (including decreases in percentage interest held) 0 0 Purchase and proceeds from the sale of intangible fixed assets (excluding goodwill) - 68 - 73 Purchase and proceeds from the sale of property, plant and equipment (excluding goodwill) - 22 - 12 Other 27 - 30 Net cash from or used in investing activities -3 226 1 682 FINANCING ACTIVITIES Cons. stat. of Purchase or sale of treasury shares changes in equity 0 - 317 Issue or repayment of promissory notes and other debt securities 4.1 407 - 238 Proceeds from or repayment of subordinated liabilities 4.1 - 119 1 604 Cons. stat. of |
|---|
| Proceeds from the issuance of share capital changes in equity 0 0 |
| Consolidated |
| statement of Issue or call of additional tier-1 instruments changes in equity 0 - 500 |
| Cons. stat. of |
| Dividends paid changes in equity 0 0 |
| Cons. stat. of |
| Coupon additional Tier-1 instruments changes in equity - 40 - 31 |
| Net cash from or used in financing activities 248 518 |
| CHANGE IN CASH AND CASH EQUIVALENTS |
| Net increase or decrease in cash and cash equivalents -1 806 13 458 |
| Cash and cash equivalents at the beginning of the period 61 407 53 961 |
| Effects of exchange rate changes on opening cash and cash equivalents 246 - 606 |
| Cash and cash equivalents at the end of the period 59 847 66 812 |
| COMPONENTS OF CASH AND CASH EQUIVALENTS |
| Cons. |
| Cash and cash balances with central banks and other demand deposits with credit institutions balance sheet 29 617 45 236 |
| Term loans to banks at not more than three months (excl. reverse repos) 4.1 741 956 |
| Reverse repos with credit institutions at not more than three months 4.1 36 295 24 833 |
| Deposits from banks repayable on demand 4.1 -6 806 -4 213 |
| Cash and cash equivalents belonging to disposal groups 0 0 |
| Total 59 847 66 812 |
| of which not available 0 0 |
The net cash from operating activities in 1Q 2025 (+1 172 million euros) mainly includes the result before tax, an increase in savings accounts, demand deposits and repos, almost fully offset by lower time deposits, the repayment of certificates of deposits and the increase of mortgage and term loans. The net cash from operating activities in 1Q 2024 (+11 258 million euros) mainly includes an increase in time deposits and repos and the issuance of certificates of deposit, partly offset by lower demand deposits and repayment of most of the remaining outstanding amount borrowed under TLTRO III (-2.2 billion euros).
The net cash from (used in) investing activities in 1Q 2025 (-3 226 million euros) mainly includes additional net purchases of debt securities at amortised cost (-3 164 million euros). The net cash from (used in) investing activities in 1Q 2024 (+1 682 million euros) mainly includes net proceeds from debt securities at amortised cost (+ 1 796 million euros).
The net cash flow from financing activities in 1Q 2025 (+248 million euros) mainly includes the issuance of new senior holdco (1 250 million euros) partly offset by the repayment of senior holdco (750 million eurs) and the repayment of subordinated loans (119 million euros), mainly KBC Ifima. The net cash flow from financing activities in 1Q 2024 (+518 million euros) includes the issuance of new Tier-2 instruments (1 billion euros and 500 million British pounds) offset by the repayment of an Additional Tier-1 instrument (500 million euros) and the purchase of treasury shares (317 million euros).
The condensed interim financial statements of the KBC Group for the period ended 31 March 2025 have been prepared in accordance with IAS 34, 'Interim financial reporting' . The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2024, which have been prepared in accordance with the IFRS Accounting Standards as adopted by the European Union ('endorsed IFRS').
The following IFRS standards were issued but not yet effective in 2025. KBC will apply these standards when they become mandatory.
The IASB published several limited amendments to existing IFRSs and IFRICs. They will be applied when they become mandatory, but their impact is currently estimated to be negligible.
A summary of the main accounting policies is provided in the group's annual accounts as at 31 December 2024.
| Average exchange rate in 1Q 2025 | ||||
|---|---|---|---|---|
| Changes relative to 31-12-2024 | Changes relative to the average 1Q 2024 | |||
| 1 EUR = … | Positive: appreciation relative to EUR | 1 EUR = … | Positive: appreciation relative to EUR | |
| … currency | Negative: depreciation relative to EUR | … currency | Negative: depreciation relative to EUR | |
| CZK | 24.962 | 1% | 25.090 | 0% |
| HUF | 402.35 | 2% | 404.77 | -4% |
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2024.
| Belgium | Czech Republic |
International Markets |
Of | |||||
|---|---|---|---|---|---|---|---|---|
| (in millions of EUR) | Business unit |
Business unit |
Business unit |
which: Hungary |
Slovakia | Bulgaria | Group Centre |
Total |
| 1Q 2025 | ||||||||
| Net interest income | 830 | 336 | 328 | 144 | 72 | 112 | - 73 | 1 421 |
| Insurance revenues before reinsurance | 471 | 156 | 143 | 55 | 28 | 60 | 3 | 773 |
| Non-life | 390 | 130 | 126 | 49 | 22 | 54 | 3 | 648 |
| Life | 81 | 26 | 18 | 6 | 6 | 6 | 0 | 125 |
| Dividend income | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
- 71 | 17 | 10 | 6 | 4 | - 1 | 0 | - 45 |
| Net fee and commission income | 454 | 94 | 143 | 81 | 23 | 39 | - 1 | 690 |
| Net other income | 61 | 2 | 5 | 1 | 3 | 1 | - 1 | 67 |
| TOTAL INCOME | 1 753 | 605 | 629 | 287 | 130 | 212 | - 72 | 2 915 |
| Operating expenses (excluding opex allocated to insurance service expenses) |
- 900 | - 228 | - 332 | - 188 | - 64 | - 81 | - 38 | -1 498 |
| Total Opex without banking and insurance tax | - 628 | - 231 | - 213 | - 79 | - 67 | - 67 | - 35 | -1 106 |
| Total Banking and insurance tax | - 356 | - 25 | - 155 | - 128 | - 4 | - 22 | - 4 | - 539 |
| Minus: Opex allocated to insurance service expenses |
84 | 28 | 35 | 20 | 7 | 9 | 1 | 148 |
| Insurance service expenses before reinsurance | - 383 | - 115 | - 124 | - 54 | - 25 | - 46 | 0 | - 622 |
| Of which insurance commissions paid | - 63 | - 21 | - 18 | - 3 | - 4 | - 11 | 0 | - 102 |
| Non-Life | - 330 | - 100 | - 113 | - 50 | - 21 | - 43 | 0 | - 543 |
| Of which Non-life - Claim related expenses | - 224 | - 58 | - 56 | - 18 | - 13 | - 25 | 1 | - 337 |
| Life | - 53 | - 14 | - 11 | - 4 | - 4 | - 3 | 0 | - 79 |
| Net result from reinsurance contracts held | - 4 | - 5 | - 3 | - 1 | - 1 | - 2 | 3 | - 9 |
| Impairment | - 24 | - 14 | - 4 | 0 | 2 | - 6 | 3 | - 38 |
| of which on FA at AC and at fair value through OCI | - 24 | - 14 | - 4 | 0 | 2 | - 6 | 3 | - 38 |
| Share in results of associated companies and joint ventures | 1 | - 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 443 | 243 | 165 | 45 | 43 | 77 | - 104 | 747 |
| Income tax expense | - 163 | - 36 | - 30 | - 10 | - 9 | - 11 | 27 | - 202 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 281 | 207 | 135 | 35 | 34 | 66 | - 77 | 546 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 281 | 207 | 135 | 35 | 34 | 66 | - 77 | 546 |
| Czech | International | |||||||
|---|---|---|---|---|---|---|---|---|
| Belgium | Republic | Markets | Of | |||||
| (in millions of EUR) | Business unit |
Business unit |
Business unit |
which: Hungary |
Slovakia | Bulgaria | Group Centre |
Total |
| 1Q 2024 | ||||||||
| Net interest income | 809 | 315 | 324 | 149 | 67 | 107 | - 79 | 1 369 |
| Insurance revenues before reinsurance | 443 | 138 | 130 | 52 | 26 | 53 | 4 | 714 |
| Non-life | 365 | 114 | 116 | 47 | 21 | 48 | 4 | 598 |
| Life | 78 | 24 | 15 | 5 | 5 | 5 | 0 | 116 |
| Dividend income | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
- 101 | 22 | 26 | 22 | 3 | 0 | - 1 | - 55 |
| Net fee and commission income | 409 | 84 | 122 | 63 | 21 | 37 | - 1 | 614 |
| Net other income | 54 | 5 | 6 | 3 | 3 | 0 | - 7 | 58 |
| TOTAL INCOME | 1 621 | 564 | 608 | 289 | 121 | 197 | - 85 | 2 708 |
| Operating expenses (excluding opex allocated to insurance service expenses) |
- 841 | - 229 | - 326 | - 179 | - 64 | - 83 | - 36 | -1 431 |
| Total Opex without banking and insurance tax | - 606 | - 220 | - 200 | - 69 | - 62 | - 70 | - 37 | -1 063 |
| Total Banking and insurance tax | - 317 | - 35 | - 167 | - 137 | - 9 | - 21 | 1 | - 518 |
| Minus: Opex allocated to insurance service expenses |
82 | 26 | 41 | 27 | 7 | 8 | 1 | 150 |
| Insurance service expenses before reinsurance | - 340 | - 99 | - 125 | - 66 | - 24 | - 35 | 1 | - 563 |
| Of which insurance commissions paid | - 57 | - 17 | - 15 | - 2 | - 3 | - 9 | 0 | - 89 |
| Non-Life | - 289 | - 86 | - 116 | - 63 | - 21 | - 32 | 1 | - 489 |
| Of which Non-life - Claim related expenses | - 191 | - 49 | - 55 | - 25 | - 13 | - 17 | 2 | - 293 |
| Life | - 52 | - 13 | - 9 | - 3 | - 3 | - 3 | 0 | - 73 |
| Net result from reinsurance contracts held | - 24 | - 4 | 0 | 5 | - 1 | - 4 | 10 | - 18 |
| Impairment | - 37 | - 4 | 20 | 11 | 11 | - 2 | 4 | - 16 |
| of which on FA at AC and at fair value through OCI | - 37 | - 4 | 20 | 10 | 11 | - 2 | 4 | - 16 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 380 | 229 | 177 | 60 | 43 | 74 | - 105 | 680 |
| Income tax expense | - 137 | - 33 | - 30 | - 10 | - 9 | - 11 | 26 | - 175 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 242 | 197 | 146 | 50 | 34 | 63 | - 80 | 506 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 243 | 197 | 146 | 50 | 34 | 63 | - 80 | 506 |
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 1Q 2024 |
|---|---|---|---|
| Total | 1 421 | 1 433 | 1 369 |
| Interest income | 4 421 | 4 620 | 5 123 |
| Interest income on financial instruments calculated using the effective interest rate method | |||
| Financial assets at AC | 2 343 | 2 396 | 2 484 |
| Financial assets at FVOCI | 159 | 153 | 103 |
| Hedging derivatives | 1 305 | 1 383 | 1 559 |
| Financial liabilities (negative interest) | 1 | 1 | 2 |
| Other | 298 | 317 | 501 |
| Interest income on other financial instruments | |||
| Financial assets MFVPL other than held for trading | 20 | 19 | 16 |
| Financial assets held for trading | 296 | 350 | 459 |
| Of which economic hedges | 246 | 298 | 415 |
| Other financial assets at FVPL | 0 | 0 | 0 |
| Interest expense | -3 000 | -3 187 | -3 754 |
| Interest expense on financial instruments calculated using the effective interest rate method | |||
| Financial liabilities at AC | -1 444 | -1 534 | -1 751 |
| Financial assets (negative interest) | - 1 | 0 | - 1 |
| Hedging derivatives | -1 290 | -1 350 | -1 523 |
| Other | - 1 | - 1 | - 1 |
| Interest expense on other financial instruments | |||
| Financial liabilities held for trading | - 256 | - 292 | - 460 |
| Of which economic hedges | - 247 | - 283 | - 446 |
| Other financial liabilities at FVPL | - 10 | - 11 | - 19 |
| Net interest expense relating to defined benefit plans | 2 | 2 | 1 |
The interest income on financial instruments calculated using the effective interest rate method – other, is mainly related to interest income on cash balances with central banks. These cash and cash balances are mainly funded with short term liabilities, such as certificates of deposits and repos. The interest expense related to this funding is part of interest expense on financial liabilities at AC. Net interest margin on this activity is narrow, resulting in limited net interest income.
The impact on net interest income of central banks' Minimum Reserve Requirements (MRR) (and their remuneration on these deposits) was about -43 million euros in 1Q 2025, compared to -41 million euros in 4Q 2024 and -52 million euros in 1Q 2024.
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 1Q 2024 |
|---|---|---|---|
| Total | - 45 | - 74 | - 55 |
| Breakdown by driver | |||
| Dealing room income | 77 | 66 | 102 |
| MTM ALM derivatives and other | - 55 | - 68 | - 102 |
| Market value adjustments (xVA) | - 1 | - 6 | 5 |
| Result on investment backing UL contracts - under IFRS 17 & Insurance finance income and expense | - 67 | - 66 | - 60 |
The result from financial instruments at fair value through profit or loss and Insurance finance income and expenses in 1Q 2025 is 29 million euros less negative compared to 4Q 2024.
The quarter-on-quarter evolution is explained as follows:
The result from financial instruments at fair value through profit or loss and Insurance finance income and expenses in 1Q 2025 is 10 million euros less negative compared to 1Q 2024.
The year-on-year evolution is for a large part explained by:
• Less negative MTM ALM derivatives and other income in 1Q 2025 compared to 1Q 2024
Partly offset by
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 1Q 2024 |
|---|---|---|---|
| Total | 690 | 700 | 614 |
| Fee and commission income | 854 | 875 | 774 |
| Fee and commission expense | - 164 | - 175 | - 160 |
| Breakdown by type | |||
| Asset Management Services | 379 | 384 | 338 |
| Fee and commission income | 391 | 398 | 353 |
| Fee and commission expense | - 12 | - 13 | - 15 |
| Banking Services | 298 | 304 | 261 |
| Fee and commission income | 448 | 465 | 404 |
| Fee and commission expense | - 150 | - 160 | - 143 |
| Other | 13 | 11 | 15 |
| Fee and commission income | 15 | 12 | 18 |
| Fee and commission expense | - 2 | - 1 | - 2 |
• Asset Management Services include management fees, entry fees and distribution fees on mutual funds and unit-linked life products (under IFRS 9).
• Banking Services include credit- and guarantee related fees, payment service fees, network income, securities related fees, distribution fees banking products and other banking services.
• The distribution commissions paid regarding insurance contracts (life and non-life under IFRS 17) are presented in the income statement as Insurance Service Expenses (for more information, see note 3.7).
• The line Other includes distribution fees from third party insurance companies (not under IFRS 17) and platformication revenues
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 1Q 2024 |
|---|---|---|---|
| Total | 67 | 27 | 58 |
| of which gains or losses on | |||
| Sale of debt securities measured at amortised cost | - 9 | - 7 | - 10 |
| Sale of debt securities at FVOCI | 2 | 1 | 0 |
| Repurchase of financial liabilities measured at amortised cost | 0 | 0 | 0 |
| of which other, including: | 74 | 33 | 68 |
| Income from operational leasing activities | 32 | 28 | 28 |
| Income from VAB Group | 14 | 13 | 13 |
| Legal cases | 0 | - 28 | 0 |
In 1Q 2025: Net other income is higher than the normal run rate of 50 million euros due mainly to higher-than-average gains on the sale of real estate.
In 4Q 2024: legal case in Hungary (-28 million euros)
In 1Q 2024: no special items
The table below includes intragroup transactions between bank and insurance entities (the results for insurance contracts concluded between the group's bank and insurance entities, interest that insurance companies receive on their deposits with bank entities, distribution commissions intra-group…) in order to give a more accurate view of the profitability of the insurance business.
| participating Non (in millions of EUR) Life (VFA) Non-life technical Total 1Q 2025 Insurance service result 46 3 107 — 153 Insurance revenues before reinsurance 125 7 651 — 776 Insurance service expenses - 79 - 4 - 544 — - 622 Of which Non-life - Claim related expenses — — - 337 — - 337 Investment result and insurance finance income and expenses 31 0 8 1 40 Investment result 76 - 9 21 1 97 Net interest income 82 0 19 2 102 Dividend income 4 0 1 0 5 Net result from financial instruments at fair value through P&L - 11 - 9 0 0 - 11 Net other income 1 0 1 - 1 0 Impairment 0 0 0 0 0 Total insurance finance income and expenses before reinsurance - 45 9 - 12 — - 57 Interest accretion - 54 — - 12 — - 67 Effect of changes in financial assumptions and foreign exchange differences 0 0 0 — 0 Changes in fair value re. liabilities of IFRS 17 unit linked contracts 9 9 — — 9 Net insurance and investment result before reinsurance 77 3 116 1 193 Net result from reinsurance contracts held - 1 — - 9 — - 9 Premiums paid to the reinsurer - 9 — - 27 — - 36 Commissions received 0 — 2 — 2 Amounts recoverable from reinsurer 8 — 16 — 24 Total (ceded) reinsurance finance income and expense 0 — 0 — 0 Net insurance and investment result after reinsurance 76 3 107 1 184 Non-directly attributable income and expenses 6 0 - 14 6 - 2 Net fee and commission income 21 0 0 7 28 Net other income — — — 23 23 Operating expenses (incl. banking and insurance tax) - 15 0 - 13 - 24 - 53 Impairment - Other 0 0 0 0 0 Share in results of assoc. comp & joint-ventures — — — 0 0 Income tax — — — - 42 - 42 Result after tax 82 3 93 - 35 140 Attributable to minority interest — — — — — Attributable to equity holders of the parent — — — — 140 |
of which life | |||
|---|---|---|---|---|
| direct | ||||
| of which life direct |
|||||
|---|---|---|---|---|---|
| (in millions of EUR) | Life | participating (VFA) |
Non-life | Non technical |
Total |
| 1Q 2024 | |||||
| Insurance service result | 43 | 3 | 110 | — | 153 |
| Insurance revenues before reinsurance | 116 | 6 | 600 | — | 717 |
| Insurance service expenses | - 73 | - 3 | - 490 | — | - 564 |
| Of which Non-life - Claim related expenses | — | — | - 293 | — | - 293 |
| Investment result and insurance finance income and expenses | 36 | 0 | 7 | 0 | 43 |
| Investment result on assets | 121 | 36 | 17 | 0 | 138 |
| Net interest income | 80 | 0 | 15 | 0 | 95 |
| Dividend income | 4 | 0 | 1 | 0 | 5 |
| Net result from financial instruments at fair value through P&L | 37 | 35 | 0 | 0 | 37 |
| Net other income | 1 | 0 | 0 | 0 | 1 |
| Impairment | 1 | 0 | 0 | 0 | 1 |
| Total insurance finance income and expenses before reinsurance |
- 85 | - 36 | - 10 | — | - 95 |
| Interest accretion | - 49 | — | - 11 | — | - 60 |
| Effect of changes in financial assumptions and foreign exchange differences |
0 | 0 | 0 | — | 0 |
| Changes in fair value re. liabilities of IFRS 17 unit linked contracts | - 36 | - 36 | — | — | - 36 |
| Net insurance and investment result before reinsurance | 80 | 3 | 117 | 0 | 196 |
| Net result from reinsurance contracts held | - 3 | — | - 15 | — | - 18 |
| Premiums paid to the reinsurer | - 10 | — | - 26 | — | - 37 |
| Commissions received | 1 | — | 3 | — | 4 |
| Amounts recoverable from reinsurer | 6 | — | 9 | — | 16 |
| Total (ceded) reinsurance finance income and expenses | 0 | — | - 1 | — | - 1 |
| Net insurance and investment result after reinsurance | 77 | 3 | 102 | 0 | 178 |
| Non-directly attributable income and expenses | 4 | 0 | - 13 | 6 | - 3 |
| Net fee and commission income | 18 | 0 | 0 | 10 | 28 |
| Net other income | — | — | — | 18 | 18 |
| Operating expenses (incl. banking and insurance tax) | - 15 | 0 | - 12 | - 22 | - 49 |
| Impairment - Other | 0 | 0 | 0 | 0 | 0 |
| Share in results of assoc. comp & joint-ventures | — | — | — | 0 | 0 |
| Income tax | — | — | — | - 42 | - 42 |
| Result after tax | 80 | 3 | 89 | - 36 | 133 |
| Attributable to minority interest | — | — | — | — | — |
| Attributable to equity holders of the parent | — | — | — | — | 133 |
The non-technical account includes also results of non-insurance companies such as VAB group and ADD.
The column 'of which life direct participating (VFA)' relates to results of long-term unit-linked contracts in Central and Eastern Europe.
Total insurance finance income and expenses before reinsurance includes changes in fair value of underlying assets of contracts measured under VFA, which represents the fair value movement of unit-linked liabilities, valued under IFRS 17 (variable fee approach), with the offsetting impact in fair value movement of underlying unit-linked assets in net result from financial instruments at fair value through profit or loss (see also note 3.3, result on investment backing UL contracts - under IFRS 17).
Amounts recoverable from reinsurer for Life also contains profit sharing (if any).
The total Operating expenses by nature include also Opex allocated to insurance service expenses (directly attributable from insurance) in order to provide a comprehensive overview of the total cost evolution.
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 1Q 2024 |
|---|---|---|---|
| Total Operating expenses by nature | -1 646 | -1 257 | -1 582 |
| Staff Expenses | - 690 | - 683 | - 663 |
| General administrative expenses | - 857 | - 474 | - 826 |
| ICT Expenses | - 154 | - 176 | - 144 |
| Facility Expenses | - 60 | - 68 | - 60 |
| Marketing & communication expenses | - 18 | - 44 | - 19 |
| Professional fees | - 31 | - 42 | - 32 |
| Bank and insurance tax | - 539 | - 55 | - 518 |
| Other | - 55 | - 89 | - 52 |
| Depreciation and amortisation of fixed assets | - 99 | - 100 | - 92 |
The operating expenses for 1Q 2025 include -539 million euros related to bank and insurance levies (-55 million euros in 4Q 2024; -518 million euros in 1Q 2024). Application of IFRIC 21 (Levies) has as a consequence that the majority of the levies are taken upfront in expense of the first quarter of the year.
The increase of bank and insurance tax in 1Q 2025 compared to 1Q 2024 is primarily driven by higher Deposit Guarantee Fund contribution in Belgium (following increased amount of covered deposits), only partly compensated by lower Single Resolution Fund contribution in Czech Republic and lower national taxes in Slovakia and Hungary.
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 1Q 2024 |
|---|---|---|---|
| Total | - 38 | - 78 | - 16 |
| Impairment on financial assets at AC and at FVOCI | - 38 | - 50 | - 16 |
| By IFRS category | |||
| Impairment on financial assets at AC | - 38 | - 50 | - 16 |
| Impairment on financial assets at FVOCI | 0 | 0 | 0 |
| By product | |||
| Loans and advances | - 41 | - 59 | - 16 |
| Debt securities | 0 | 0 | - 1 |
| Off-balance-sheet commitments and financial guarantees | 3 | 10 | 0 |
| By type | |||
| Stage 1 (12-month ECL) | - 5 | - 34 | - 36 |
| Stage 2 (lifetime ECL) | 46 | 77 | 95 |
| Stage 3 (non-performing; lifetime ECL) | - 62 | - 78 | - 53 |
| Purchased or originated credit impaired assets | - 18 | - 15 | - 22 |
| By division/country | |||
| Belgium | - 24 | - 48 | - 37 |
| Czech Republic | - 14 | 13 | - 4 |
| International Markets | - 4 | 0 | 20 |
| Slovakia | 2 | 4 | 11 |
| Hungary | 0 | - 1 | 10 |
| Bulgaria | - 6 | - 3 | - 2 |
| Group Centre | 3 | - 15 | 4 |
| Impairment on goodwill | 0 | 0 | 0 |
| Impairment on other | 0 | - 28 | 0 |
| Intangible fixed assets (other than goodwill) | 0 | - 24 | 0 |
| Property, plant and equipment (including investment property) | 0 | 1 | 0 |
| Associated companies and joint ventures | 0 | 0 | 0 |
| Other | 0 | - 5 | 0 |
The impairment on financial assets at AC and at FVOCI in 1Q 2025 include:
• A net impairment release of 45 million euros for the geopolitical and macroeconomic uncertainties, compared to 50 million euros release in 4Q 2024 and 27 million euros release in 1Q 2024). The 45 million euros ECL release in 1Q 2025 is driven mainly by the evolution of micro- and macroeconomic indicators.
The outstanding balance of ECL for the geopolitical and macroeconomic uncertainties amounts to 72 million euros at the end of 1Q 2025. As a reminder, this is determined based on individual counterparties and sectors deemed to have incurred an increase in credit risk because they are either exposed to macroeconomic risks (e.g. high(er) inflation, high(er) interest rates, high(er) energy prices, …) or indirectly exposed to military conflicts, such as the one in Ukraine.
• Additionally, the impairments on financial assets at AC and at FVOCI in 1Q 2025 include 83 million euros net charge, compared to 100 million euros in 4Q 2024 and 43 million euros in 1Q 2024, largely in stage 3 mainly for a limited number of large corporate files in the business units Belgium and Czech Republic. The impairments on financial assets at AC and at FVOCI in 1Q 2025 include 41 million euros additional impairments reducing the backstop shortfall for old non-performing loans in Belgium, compared to 18 million euros in 4Q 2024.
The impairments on intangible asset (other than goodwill) in 4Q 2024 (-24 million euros) are related to software impairments in most countries.
The impairment on other (Other) in 4Q 2024 (-5 million euros) are mainly related to modification losses, following the extension of the interest cap regulation for mortgages in Hungary until 30 June 2025.
As was mentioned in the 4Q 2024 quarterly report and the 2024 annual report, the results of 4Q 2024 included a tax benefit (deferred income tax) in P&L of 318 million euros in Group Centre regarding the forthcoming liquidation of Exicon (ex-KBC Bank Ireland).
| Meas | |||||||
|---|---|---|---|---|---|---|---|
| ured at | |||||||
| fair value | Mandatorily | ||||||
| through | measured at | ||||||
| Meas | other | fair value | |||||
| ured at | compre | through profit | Desig | ||||
| amor tised |
hensive income |
or loss (MFVPL) excl. |
Held for trading |
nated at fair value |
Hedging deriva |
||
| (in millions of EUR) | cost (AC) | (FVOCI) | HFT | (HFT) | (FVO) | tives | Total |
| FINANCIAL ASSETS, 31-03-2025 | |||||||
| Loans and advances to credit institutions (excl. reverse | |||||||
| repos) | 2 486 | 0 | 0 | 1 | 0 | 0 | 2 486 |
| of which repayable on demand and term loans at not more than three months |
741 | ||||||
| Loans and advances to customers (excl. reverse repos) | 196 286 | 0 | 1 012 | 27 | 0 | 0 | 197 326 |
| Trade receivables | 3 052 | 0 | 0 | 0 | 0 | 0 | 3 052 |
| Consumer credit | 6 507 | 0 | 676 | 0 | 0 | 0 | 7 183 |
| Mortgage loans | 79 094 | 0 | 335 | 0 | 0 | 0 | 79 429 |
| Term loans | 93 480 | 0 | 1 | 27 | 0 | 0 | 93 508 |
| Finance lease | 7 993 | 0 | 0 | 0 | 0 | 0 | 7 993 |
| Current account advances | 5 235 | 0 | 0 | 0 | 0 | 0 | 5 235 |
| Other | 925 | 0 | 0 | 0 | 0 | 0 | 925 |
| Reverse repos | 37 011 | 0 | 0 | 602 | 0 | 0 | 37 614 |
| with credit institutions | 36 870 | 0 | 0 | 602 | 0 | 0 | 37 473 |
| with customers | 141 | 0 | 0 | 0 | 0 | 0 | 141 |
| Equity instruments | 0 | 1 690 | 10 | 965 | 0 | 0 | 2 665 |
| Unit linked investments (insurance) | 0 | 0 | 16 535 | 0 | 0 | 0 | 16 535 |
| Debt securities issued by | 53 399 | 23 440 | 71 | 4 844 | 0 | 0 | 81 754 |
| Public bodies | 46 106 | 19 181 | 0 | 3 505 | 0 | 0 | 68 792 |
| Credit institutions | 5 171 | 2 440 | 0 | 1 277 | 0 | 0 | 8 887 |
| Corporates | 2 123 | 1 819 | 71 | 63 | 0 | 0 | 4 075 |
| Derivatives | 0 | 0 | 0 | 3 476 | 0 | 267 | 3 743 |
| Other | 1 213 | 0 | 0 | 0 | 0 | 0 | 1 213 |
| Total | 290 395 | 25 130 | 17 628 | 9 915 | 0 | 267 | 343 335 |
| FINANCIAL ASSETS, 31-12-2024 | |||||||
| Loans and advances to credit institutions (excl. reverse repos) |
2 438 | 0 | 0 | 1 | 0 | 0 | 2 439 |
| of which repayable on demand and term loans at not more than three months |
225 | ||||||
| Loans and advances to customers (excl. reverse repos) | 191 124 | 0 | 943 | 0 | 0 | 0 | 192 067 |
| Trade receivables | 2 887 | 0 | 0 | 0 | 0 | 0 | 2 887 |
| Consumer credit | 6 316 | 0 | 633 | 0 | 0 | 0 | 6 949 |
| Mortgage loans | 77 750 | 0 | 309 | 0 | 0 | 0 | 78 059 |
| Term loans | 90 754 | 0 | 1 | 0 | 0 | 0 | 90 755 |
| Finance lease | 7 919 | 0 | 0 | 0 | 0 | 0 | 7 919 |
| Current account advances | 4 790 | 0 | 0 | 0 | 0 | 0 | 4 790 |
| Other | 708 | 0 | 0 | 0 | 0 | 0 | 708 |
| Reverse repos | 21 083 | 0 | 0 | 0 | 0 | 0 | 21 083 |
| with credit institutions | 20 922 | 0 | 0 | 0 | 0 | 0 | 20 922 |
| with customers | 162 | 0 | 0 | 0 | 0 | 0 | 162 |
| Equity instruments | 0 | 1 722 | 10 | 902 | 0 | 0 | 2 633 |
| Unit linked investments (insurance) | 0 | 0 | 16 602 | 0 | 0 | 0 | 16 602 |
| Debt securities issued by | 50 075 | 22 539 | 70 | 5 021 | 0 | 0 | 77 705 |
| Public bodies | 41 955 | 18 165 | 0 | 3 360 | 0 | 0 | 63 480 |
| Credit institutions | 5 982 | 2 510 | 0 | 1 593 | 0 | 0 | 10 085 |
| Corporates | 2 139 | 1 864 | 70 | 68 | 0 | 0 | 4 140 |
| Derivatives | 0 | 0 | 0 | 4 584 | 0 | 271 | 4 856 |
| Other | 1 154 | 0 | 0 | 0 | 0 | 0 | 1 154 |
| Total | 265 875 | 24 261 | 17 624 | 10 509 | 0 | 271 | 318 540 |
| Measured at | Held for | ||||
|---|---|---|---|---|---|
| amortised cost | trading | Designated at fair | Hedging | ||
| (in millions of EUR) FINANCIAL LIABILITIES, 31-03-2025 |
(AC) | (HFT) | value (FVO) | derivatives | Total |
| Deposits from credit institutions (excl. repos) | 13 500 | 0 | 0 | 0 | 13 500 |
| of which repayable on demand | 6 806 | ||||
| Deposits from customers and debt securities (excl. | |||||
| repos) | 270 685 | 23 | 1 007 | 0 | 271 716 |
| Demand deposits | 111 561 | 0 | 0 | 0 | 111 561 |
| Time deposits | 40 706 | 23 | 217 | 0 | 40 946 |
| Savings accounts | 77 261 | 0 | 0 | 0 | 77 261 |
| Savings certificates | 1 254 | 0 | 0 | 0 | 1 254 |
| Subtotal, customer deposits | 230 781 | 23 | 217 | 0 | 231 022 |
| Certificates of deposit | 12 405 | 0 | 6 | 0 | 12 410 |
| Non-convertible bonds | 24 590 | 0 | 784 | 0 | 25 374 |
| Non-convertible subordinated liabilities | 2 909 | 0 | 0 | 0 | 2 909 |
| Repos | 25 061 | 245 | 0 | 0 | 25 305 |
| with credit institutions | 13 791 | 133 | 0 | 0 | 13 924 |
| with customers | 11 269 | 112 | 0 | 0 | 11 381 |
| Liabilities under investment contracts | 27 | 0 | 15 603 | 0 | 15 631 |
| Derivatives | 0 | 4 452 | 0 | 286 | 4 738 |
| Short positions | 0 | 954 | 0 | 0 | 954 |
| In equity instruments | 0 | 6 | 0 | 0 | 6 |
| In debt securities | 0 | 948 | 0 | 0 | 948 |
| Other | 2 790 | 1 | 0 | 0 | 2 791 |
| Total | 312 064 | 5 674 | 16 611 | 286 | 334 634 |
| FINANCIAL LIABILITIES, 31-12-2024 | |||||
| Deposits from credit institutions (excl. repos) | 12 852 | 0 | 0 | 0 | 12 852 |
| of which repayable on demand | 6 456 | ||||
| Deposits from customers and debt securities (excl. | 270 030 | 22 | 1 035 | 0 | 271 087 |
| repos) | |||||
| Demand deposits | 110 090 | 0 | 0 | 0 | 110 090 |
| Time deposits | 42 781 | 22 | 163 | 0 | 42 966 |
| Savings accounts | 74 440 | 0 | 0 | 0 | 74 440 |
| Savings certificates | 1 250 | 0 | 0 | 0 | 1 250 |
| Subtotal, customer deposits | 228 562 | 22 | 163 | 0 | 228 747 |
| Certificates of deposit | 14 376 | 0 | 5 | 0 | 14 382 |
| Non-convertible bonds | 24 185 | 0 | 745 | 0 | 24 930 |
| Non-convertible subordinated liabilities | 2 907 | 0 | 121 | 0 | 3 028 |
| Repos | 20 985 | 94 | 0 | 0 | 21 079 |
| with credit institutions | 18 587 | 94 | 0 | 0 | 18 681 |
| with customers | 2 398 | 0 | 0 | 0 | 2 398 |
| Liabilities under investment contracts | 27 | 0 | 15 644 | 0 | 15 671 |
| Derivatives | 0 | 4 679 | 0 | 316 | 4 995 |
| Short positions | 0 | 882 | 0 | 0 | 882 |
| In equity instruments | 0 | 9 | 0 | 0 | 9 |
| In debt securities | 0 | 872 | 0 | 0 | 872 |
| Other | 2 157 | 0 | 0 | 0 | 2 157 |
| Total | 306 050 | 5 677 | 16 680 | 316 | 328 723 |
| (in millions of EUR) | Carrying value before impairment |
Impairment | Carrying value after impairment |
|---|---|---|---|
| 31-03-2025 | |||
| FINANCIAL ASSETS AT AMORTISED COST | |||
| Loans and advances * | 238 191 | - 2 408 | 235 783 |
| Stage 1 (12-month ECL) | 218 855 | - 180 | 218 675 |
| Stage 2 (lifetime ECL) | 15 461 | - 288 | 15 173 |
| Stage 3 (lifetime ECL) | 3 330 | - 1 785 | 1 545 |
| Purchased or originated credit impaired assets (POCI) | 545 | - 155 | 390 |
| Debt Securities | 53 408 | - 9 | 53 399 |
| Stage 1 (12-month ECL) | 53 325 | - 6 | 53 318 |
| Stage 2 (lifetime ECL) | 79 | - 1 | 78 |
| Stage 3 (lifetime ECL) | 5 | - 2 | 3 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | |||
| Debt Securities | 23 444 | - 4 | 23 440 |
| Stage 1 (12-month ECL) | 23 437 | - 4 | 23 433 |
| Stage 2 (lifetime ECL) | 6 | 0 | 6 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| 31-12-2024 | |||
| FINANCIAL ASSETS AT AMORTISED COST | |||
| Loans and advances * | 217 093 | - 2 448 | 214 645 |
| Stage 1 (12-month ECL) | 197 031 | - 176 | 196 855 |
| Stage 2 (lifetime ECL) | 16 177 | - 331 | 15 847 |
| Stage 3 (lifetime ECL) | 3 472 | - 1 803 | 1 669 |
| Purchased or originated credit impaired assets (POCI) | 414 | - 138 | 276 |
| Debt Securities | 50 084 | - 8 | 50 075 |
| Stage 1 (12-month ECL) | 49 979 | - 6 | 49 973 |
| Stage 2 (lifetime ECL) | 100 | - 1 | 99 |
| Stage 3 (lifetime ECL) | 5 | - 2 | 3 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | |||
| Debt Securities | 22 543 | - 4 | 22 539 |
| Stage 1 (12-month ECL) | 22 543 | - 4 | 22 539 |
| Stage 2 (lifetime ECL) | 0 | 0 | 0 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
(*) The carrying value after impairment in this note is equal to the sum of the lines Loans and advances to credit institutions (excl. reverse repos), Loans and advances to customers (excl. reverse repos) and Reverse repos in note 4.1 (in the column Measured at amortised cost)
The difference between the fair value and the carrying value of the debt securities at amortised cost has slightly decreased from -1 870 million euros at 31 December 2024 (carrying amount of 50 075 million euros versus fair value of 48 205 million euros) to -1 864 million euros at 31 March 2025 (carrying amount of 53 399 million euros versus fair value of 51 535 million euros), mainly due to the unwinding effect offset by an increase of long-term interest rates.
As a hold-to-collect business model is applied on assets at amortised cost, interim changes in fair value are less relevant.
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2024.
| (in millions of EUR) | 31-03-2025 | 31-12-2024 | ||||||
|---|---|---|---|---|---|---|---|---|
| Fair value hierarchy | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| FINANCIAL ASSETS AT FAIR VALUE | ||||||||
| Mandatorily measured at fair value through profit or loss (other than held for trading) |
16 465 | 82 | 1 081 | 17 628 | 16 539 | 75 | 1 009 | 17 624 |
| Held for trading | 4 021 | 4 756 | 1 138 | 9 915 | 3 354 | 6 097 | 1 057 | 10 509 |
| Designated at fair value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| At fair value through OCI | 22 398 | 2 056 | 675 | 25 130 | 21 410 | 2 200 | 651 | 24 261 |
| Hedging derivatives | 0 | 267 | 0 | 267 | 0 | 271 | 0 | 271 |
| Total | 42 885 | 7 161 | 2 894 | 52 940 | 41 303 | 8 644 | 2 717 | 52 665 |
| FINANCIAL LIABILITIES AT FAIR VALUE | ||||||||
| Held for trading | 961 | 3 194 | 1 519 | 5 674 | 883 | 3 388 | 1 406 | 5 677 |
| Designated at fair value | 15 603 | 240 | 767 | 16 611 | 15 644 | 186 | 850 | 16 680 |
| Hedging derivatives | 0 | 238 | 48 | 286 | 0 | 265 | 51 | 316 |
| Total | 16 565 | 3 672 | 2 334 | 22 571 | 16 527 | 3 838 | 2 307 | 22 673 |
During 1Q 2025, KBC transferred about 298 million euros worth of financial assets and liabilities out of level 1 and into level 2. It also reclassified approximately 321 million euros worth of financial assets and liabilities from level 2 to level 1. Most of these reclassifications were carried out due to a change in the liquidity of government and corporate bonds.
In 1Q 2025 significant movements in financial assets and liabilities classified in level 3 of the fair value hierarchy included the following:
The Contractual Service Margin (CSM) as included in the insurance contract liabilities, evolved from 2 276 million euros at the end of 2024 to 2 307 million euros at 31 March 2025, or an increase of 31 million euros. This increase is mainly explained by CSM of new business (+62 million euros) which was slightly higher compared to the CSM release in the income statement (-41 million euros), reinforced by positive interest accretion (time value) on the CSM (+7 million euros).
| Quantities | 31-03-2025 | 31-12-2024 |
|---|---|---|
| Ordinary shares | 417 544 151 | 417 544 151 |
| of which ordinary shares that entitle the holder to a dividend payment | 396 563 328 | 396 563 328 |
| of which treasury shares | 20 980 825 | 20 980 825 |
| Additional information | ||
| Par value per share (in EUR) | 3.51 | 3.51 |
| Number of shares issued but not fully paid up | 0 | 0 |
The ordinary shares of KBC Group NV have no nominal value and are quoted on Euronext Brussels.
The treasury shares almost entirely relate to shares bought in the share buyback programme.
On 30 April 2024, KBC Bank Ireland returned its banking license to the Central Bank of Ireland and subsequently has been renamed as Exicon. The expected closing of the liquidation process in 3Q 2025 has led to a tax benefit (deferred income tax) in P&L of 318 million euros in 4Q 2024 (see also note 3.11 in this report). Exicon is no longer fully consolidated as of 1 January 2025 because of immateriality.
Significant non-adjusting events between the balance sheet date (31 March 2025) and the publication of this report (15 May 2025):
The figures of 1Q 2025 do not include any impact of increased trade tariffs announced on the so-called Liberation Day (on 2 April 2025), which is considered a non-adjusting subsequent event.
Furthermore, KBC reached an agreement to acquire 98.45% of 365.bank in Slovakia. Closure of the deal is subject to regulatory approval and is expected by the end of this year. For more information, please refer to page 3 of this report as well as separate press release and investor presentation on our website www.kbc.com


1Q 2025
The main source of credit risk is the loan portfolio of the bank. It includes all the loans and guarantees that KBC has granted to individuals, companies, governments and banks. Debt securities in the investment portfolio are included if they are issued by companies or banks. Government bonds are not included. The loan portfolio as defined in this section differs from 'Loans and advances to customers' in Note 4.1 of the 'Consolidated financial statements' section of the annual accounts 2024. For more information, please refer to 'Details of ratios and terms on KBC Group level'.
A snapshot of the banking portfolio is shown in the table below. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit.
| Credit risk: loan portfolio overview | 31-03-2025 | 31-12-2024 |
|---|---|---|
| Total loan portfolio (in billions of EUR) 1 | ||
| Amount outstanding and undrawn | 265 | 263 |
| Amount outstanding | 215 | 211 |
| Loan portfolio breakdown by business unit (as a % of the outstanding portfolio) | ||
| Belgium | 63.9% | 64.5% |
| Czech Republic | 20.0% | 19.4% |
| International Markets | 15.7% | 15.6% |
| Group Centre 2 | 0.4% | 0.5% |
| Loan portfolio breakdown by counterparty sector (as a % of the outstanding portfolio) | ||
| Private individuals | 40.7% | 40.8% |
| Finance and insurance | 5.5% | 5.3% |
| Governments | 3.2% | 2.9% |
| Corporates | 50.6% | 51.0% |
| Services | 10.7% | 10.7% |
| Distribution | 8.0% | 8.2% |
| Real estate 3 | 6.8% | 6.9% |
| Building & construction | 4.7% | 4.8% |
| Agriculture, farming, fishing | 2.7% | 2.7% |
| Automotive | 2.6% | 2.7% |
| Electricity | 2.0% | 1.9% |
| Food Producers | 1.8% | 2.0% |
| Metals | 1.5% | 1.5% |
| Chemicals | 1.4% | 1.4% |
| Shipping | 1.0% | 0.8% |
| Machinery & Heavy equipment | 1.0% | 0.9% |
| Oil, gas & other fuels | 0.9% | 0.9% |
| Hotels, bars & restaurants | 0.8% | 0.7% |
| Electrotechnics | 0.5% | 0.5% |
| Timber & wooden furniture | 0.5% | 0.5% |
| Other 4 | 3.7% | 3.8% |
| Loan portfolio breakdown by region (as a % of the outstanding portfolio) | ||
| Belgium | 54.3% | 54.9% |
| Czech Republic | 18.8% | 18.6% |
| Slovakia | 6.2% | 6.1% |
| Hungary | 4.0% | 4.0% |
| Bulgaria | 5.6% | 5.6% |
| Rest of Western Europe | 7.6% | 7.6% |
| Rest of Central and Eastern Europe | 0.2% | 0.2% |
| of which: Russia and Ukraine | 0.00% | 0.01% |
| North America | 1.0% | 1.1% |
| Asia | 0.9% | 0.9% |
| Other | 1.4% | 1.0% |
| Loan portfolio breakdown by counterparty (as % of the outstanding portfolio) | ||
| Retail | 40.6% | 40.7% |
| of which: mortgages | 36.7% | 36.8% |
| of which: consumer finance | 3.9% | 3.9% |
| SME | 21.8% | 22.0% |
| Corporate | 37.7% | 37.3% |
| 31-03-2025 | 31-12-2024 | |
|---|---|---|
| Loan portfolio breakdown by IFRS 9 ECL stage (as % of the outstanding portfolio) | ||
| Stage 1 (credit risk has not increased significantly since initial recognition) | 90.6% | 90.2% |
| of which: PD 1 - 4 | 64.7% | 64.5% |
| of which: PD 5 - 9 including unrated | 25.8% | 25.7% |
| Stage 2 (credit risk has increased significantly since initial recognition – not credit impaired) incl. POCI 5 | 7.5% | 7.8% |
| of which: PD 1 - 4 | 2.2% | 2.2% |
| of which: PD 5 - 9 including unrated | 5.3% | 5.6% |
| Stage 3 (credit risk has increased significantly since initial recognition – credit impaired) incl. POCI 5 | 1.9% | 2.0% |
| of which: PD 10 impaired loans | 0.9% | 0.9% |
| of which: more than 90 days past due (PD 11+12) | 1.0% | 1.0% |
| Impaired loan portfolio (in millions of EUR) | ||
| Impaired loans (PD10 + 11 + 12) | 4 126 | 4 171 |
| of which: more than 90 days past due | 2 193 | 2 178 |
| Impaired loans ratio (%) | ||
| Belgium | 1.9% | 2.0% |
| Czech Republic | 1.3% | 1.3% |
| International Markets | 1.6% | 1.6% |
| Group Centre 2 | 36.6% | 38.3% |
| Total | 1.9% | 2.0% |
| of which: more than 90 days past due | 1.0% | 1.0% |
| Loan loss impairment (in millions of EUR) | ||
| Loan loss Impairment for Stage 1 portfolio | 206 | 201 |
| Loan loss Impairment for Stage 2 portfolio | 294 | 340 |
| Loan loss Impairment for Stage 3 portfolio | 1 977 | 1 979 |
| of which: more than 90 days past due | 1 499 | 1 492 |
| Cover ratio of impaired loans (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans | 47.9% | 47.4% |
| of which: more than 90 days past due | 68.4% | 68.5% |
| Cover ratio of impaired loans, mortgage loans excluded (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans, mortgage loans excluded | 51.0% | 50.5% |
| of which: more than 90 days past due | 71.2% | 71.4% |
| Credit cost ratio (%) | ||
| Belgium | 0.07% | 0.19% |
| Czech Republic | 0.13% | -0.09% |
| International Markets | 0.05% | -0.08% |
| Slovakia | -0.08% | -0.14% |
| Hungary | 0.02% | -0.27% |
| Bulgaria | 0.20% | 0.14% |
| Group Centre | 0.22% | 1.58% |
| Total | 0.08% | 0.10% |
1Outstanding portfolio includes all on-balance sheet commitments and off-balance sheet guarantees but excludes off-balance sheet undrawn commitments; the amounts are measured in Gross Carrying Amounts
2Business Unit Group Centre = part of non-legacy portfolio assigned to BU Group, activities in wind-down (e.g. ex-Antwerp Diamond Bank). The presence of the residual portfolios of the activities in wind-down explains the high share of impaired loans
3 Real estate = Income producing commercial real estate to 3rd parties
4Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors
5Purchased or originated credit impaired assets
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2024 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the definition used by EBA.
| 31-03-2025, in millions of EUR | Business Unit Belgium1 | Business Unit Czech Republic | Business Unit International Markets | Business Unit Group Centre2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 137 801 | 42 991 | 33 821 | 873 | ||||||||
| Counterparty break down | % outst. | % outst. | % outst. | % outst. | ||||||||
| retail | 47 780 | 35% | 23 959 | 56% | 15 641 | 46% | 0 | 0% | ||||
| o/w mortgages | 46 069 | 33% | 20 972 | 49% | 12 001 | 35% | 0 | 0% | ||||
| o/w consumer finance | 1 711 | 1% | 2 987 | 7% | 3 641 | 11% | 0 | 0% | ||||
| SME | 36 651 | 27% | 6 088 | 14% | 4 216 | 12% | 0 | 0% | ||||
| corporate | 53 370 | 39% | 12 945 | 30% | 13 963 | 41% | 873 | 100% | ||||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | ||||
| total | 46 069 | 33% | 54% | 20 972 | 49% | 51% | 12 001 | 35% | 58% | 0 | 0% | 0% |
| o/w FX mortgages | 0 | 0% | - | 0 | 0% | - | 64 | 0% | 38% | 0 | 0% | - |
| o/w ind. LTV > 100% | 406 | 0% | - | 14 | 0% | - | 70 | 0% | - | 0 | 0% | - |
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | ||||||||
| low risk (PD 1-4; 0.00%-0.80%) | 101 144 | 73% | 25 442 | 59% | 17 097 | 51% | 521 | 60% | ||||
| medium risk (PD 5-7; 0.80%-6.40%) | 30 605 | 22% | 15 319 | 36% | 15 065 | 45% | 33 | 4% | ||||
| high risk (PD 8-9; 6.40%-100.00%) | 3 067 | 2% | 1 649 | 4% | 1 087 | 3% | 0 | 0% | ||||
| impaired loans (PD 10 - 12) | 2 681 | 2% | 578 | 1% | 547 | 2% | 319 | 37% | ||||
| unrated | 304 | 0% | 4 | 0% | 25 | 0% | 0 | 0% | ||||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | ||||
| outstanding impaired loans | 2 681 | 1 177 | 44% | 578 | 249 | 43% | 547 | 245 | 45% | 319 | 307 | 96% |
| o/w PD 10 impaired loans | 1 404 | 349 | 25% | 239 | 52 | 22% | 273 | 71 | 26% | 17 | 6 | 35% |
| o/w more than 90 days past due (PD 11+12) | 1 278 | 828 | 65% | 339 | 197 | 58% | 274 | 174 | 63% | 302 | 301 | 100% |
| all impairments (stage 1+2+3) | 1 401 | 394 | 375 | 307 | ||||||||
| o/w stage 1+2 impairments (incl. POCI) | 225 | 145 | 130 | 0 | ||||||||
| o/w stage 3 impairments (incl. POCI) | 1 177 | 249 | 245 | 307 | ||||||||
| 2024 Credit cost ratio (CCR)3 | 0.19% | -0.09% | -0.08% | 1.58% | ||||||||
| 2025 Credit cost ratio (CCR)3 - YTD |
0.07% | 0.13% | 0.05% | 0.22% | ||||||||
| 1 Business Unit Belgium = KBC Bank (all retail and corporate credit lending activities including the foreign branches, part of non-legacy portfolio assigned to BU Belgium), CBC, KBC Lease Belgium, KBC Immolease, KBC Commercial Finance |
||||||||||||
| 2 Business Unit Group Centre = part of non-legacy portfolio assigned to BU Group and activities in wind-down (e.g. ex-Antwerp Diamond Bank) 3 |
Loan portfolio per Business Unit
3 CCR at country level in local currency
| 31-03-2025, in millions of EUR | Slovakia | Hungary | Bulgaria | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 12 821 | 8 697 | 12 303 | ||||||
| Counterparty break down | % outst. | % outst. | % outst. | ||||||
| retail | 7 446 | 58% | 3 075 | 35% | 5 120 | 42% | |||
| o/w mortgages | 6 886 | 54% | 2 036 | 23% | 3 079 | 25% | |||
| o/w consumer finance | 560 | 4% | 1 040 | 12% | 2 041 | 17% | |||
| SME | 1 301 | 10% | 101 | 1% | 2 814 | 23% | |||
| corporate | 4 073 | 32% | 5 521 | 63% | 4 369 | 36% | |||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | |||
| total | 6 886 | 54% | 61% | 2 036 | 23% | 44% | 3 079 | 25% | 62% |
| o/w FX mortgages | 0 | 0% | - | 0 | 0% | 38% | 64 | 1% | 38% |
| o/w ind. LTV > 100% | 38 | 0% | - | 17 | 0% | 16 | 0% | - | |
| Probability of default (PD) | % outst. | % outst. | % outst. | ||||||
| low risk (PD 1-4; 0.00%-0.80%) | 8 529 | 67% | 4 591 | 53% | 3 977 | 32% | |||
| medium risk (PD 5-7; 0.80%-6.40%) | 3 514 | 27% | 3 858 | 44% | 7 693 | 63% | |||
| high risk (PD 8-9; 6.40%-100.00%) | 542 | 4% | 159 | 2% | 385 | 3% | |||
| impaired loans (PD 10 - 12) | 212 | 2% | 88 | 1% | 247 | 2% | |||
| unrated | 23 | 0% | 1 | 0% | 0 | 0% | |||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | |||
| outstanding impaired loans | 212 | 89 | 42% | 88 | 32 | 36% | 247 | 124 | 50% |
| o/w PD 10 impaired loans | 104 | 23 | 22% | 62 | 16 | 26% | 107 | 32 | 30% |
| o/w more than 90 days past due (PD 11+12) | 108 | 67 | 62% | 26 | 15 | 59% | 140 | 92 | 66% |
| all impairments (stage 1+2+3) | 124 | 68 | 183 | ||||||
| o/w stage 1+2 impairments (incl. POCI) | 34 | 36 | 59 | ||||||
| o/w stage 3 impairments (incl. POCI) | 89 | 32 | 124 | ||||||
| 2024 Credit cost ratio (CCR)1 | -0.14% | -0.27% | 0.14% | ||||||
| 2025 Credit cost ratio (CCR)3 - YTD |
-0.08% | 0.02% | 0.20% |
1 CCR at country level in local currency
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD. This regulation entered gradually into force as of 1 January 2014.
Based on CRR/CRD, profit can be included in CET1 capital only after the profit appropriation decision by the final decision body, for KBC Group it is the General Meeting. ECB can allow to include interim or annual profit in CET1 capital before the decision by the General Meeting. In that case, the foreseeable dividend should be deducted from the profit that is included in CET1. Considering that our Dividend Policy of "at least 50%" does not include a maximum, KBC Group no longer requests ECB approval to include interim or annual profit in CET1 capital before the decision by the General Meeting. As such, the annual profit of 2024 and the dividend re. 2024 have been recognised in the official (transitional) CET1 of the 1st quarter 2025, which is reported after the General Meeting.
The 2025 interim profit is only included in the fully loaded CET1 (taking into account 50% pay-out in line with our Dividend Policy). As from 2Q2025, KBC intends to resume interim profit recognition (subject to ECB approval) in transitional CET1 in line with the revised Dividend Policy. For more information see page 11 of this report.
The general rule under CRR/CRD for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). As of the fourth quarter of 2020, the revised CRR/CRD requires the use of the equity method, unless the competent authority allows institutions to apply a different method. KBC Group has received ECB approval to continue to use the historical carrying value for risk weighting (250% from 1 January 2025, 370% before), after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRR/CRD, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC). This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD for the banking business and Solvency II for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The overall capital requirement (CET1) that KBC is to uphold is set at 10.83% (fully loaded, Danish Compromise which includes the CRR/CRD minimum requirement (4.50%), the Pillar 2 Requirement (1.06% P2R, taking into account CRD V Art 104a(4)) and the buffers set by national competent authorities (2.50% Capital Conservation Buffer, 1.50% buffer for other systemically important banks, 0.11% Systemic Risk Buffer and 1.15% Countercyclical Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.25%. In line with CRD V Art. 104a(4), ECB allows banks to satisfy the P2R (1.83%, 3bps lower compared to 31 December 2024 which is explained by a lower add-on related to the back-stop shortfall for non-performing exposures defaulted before 01-04-2018) with additional tier-1 instruments (1.75% up to 1.5/8) and tier-2 instruments (1.75% up to 2/8) based on the same relative weights as allowed for meeting the 8% Pillar 1 Requirement. The CET1 requirement related to P2R now includes 100% of the 8bps add-on related to the back-stop shortfall for non-performing exposures defaulted before 01-04-2018.
Distributions (being dividend payments, payments related to additional tier 1 instruments or variable remuneration) are limited in case the combined buffer requirements described above are breached. This limitation is also referred to as "Maximum Distributable Amount" or "MDA" thresholds.
The next table provides an overview of the buffers KBC Group has compared to these thresholds, both on an actuals basis (i.e. versus the regulatory targets that apply at the reporting date) and a fully loaded basis (i.e. versus the regulatory targets that will apply going forward).
| Buffer vs. Overall Capital Requirement (in millions of EUR) |
31-03-2025 | 31-12-2024 | |||
|---|---|---|---|---|---|
| (consolidated, under CRR, Danish compromise method) | Fully loaded | Actuals | Fully loaded | Actuals | |
| CET1 Pillar 1 minimum | 4.50% | 4.50% | 4.50% | 4.50% | |
| Pillar 2 requirement to be satisfied with CET1 | 1.06% | 1.06% | 1.09% | 1.05% | |
| Capital conservation buffer | 2.50% | 2.50% | 2.50% | 2.50% | |
| Buffer for systemically important institutions (O-SII) | 1.50% | 1.50% | 1.50% | 1.50% | |
| Systemic Risk Buffer (SRyB) | 0.11% | 0.11% | 0.14% | 0.14% | |
| Entity-specific countercyclical buffer | 1.15% | 1.12% | 1.15% | 1.12% | |
| Overall Capital Requirement (OCR) - with P2R split, CRD Art. 104a(4) | 10.83% | 10.80% | 10.88% | 10.80% | |
| CET1 used to satisfy shortfall in AT1 bucket | 0.33% | 0.31% | 0.27% | 0.29% | |
| CET1 used to satisfy shortfall in T2 bucket | 0.31% | 0.29% | 0.30% | 0.33% | |
| CET1 requirement for MDA | 11.47% | 11.40% | 11.45% | 11.42% | |
| CET1 capital | 18 047 | 17 937 | 17 947 | 16 621 | |
| CET1 buffer (= buffer compared to MDA) | 3 735 | 3 912 | 4 212 | 2 919 |
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| Overview of KBC Group's capital ratios | denominator | |||
|---|---|---|---|---|
| (in millions of EUR) | numerator (common |
(total weighted |
||
| 31-03-2025 | equity) | risk volume) | ratio (%) | |
| Common Equity ratio | ||||
| Danish Compromise | Fully loaded | 18 047 | 124 789 | 14.46% |
| Deduction Method | Fully loaded | 17 411 | 123 200 | 14.13% |
| Financial Conglomerates Directive | Fully loaded | 19 803 | 145 753 | 13.59% |
| Danish Compromise | Transitional | 17 937 | 123 005 | 14.58% |
| Deduction Method | Transitional | 17 284 | 121 373 | 14.24% |
| Financial Conglomerates Directive | Transitional | 19 693 | 143 970 | 13.68% |
KBC's fully loaded CET1 ratio of 14.46% at the end of March 2025 represents a solid capital buffer of 2.99% compared with the Maximum Distributable Amount (MDA) of 11.47%.
The Annual General Meeting of shareholders (on 30 April 2025) approved a gross dividend of 4.85 euros per share related to the accounting year 2024, of which:
Therefore, reflecting a pay-out ratio (including 4.15 euros per share and AT1-coupon) of approximately 51% of 2024 net profit.
The EBA Monitoring report on AT1, Tier 2 and TLAC / MREL eligible liabilities instruments (27 June 2024) recommends to use the carrying amounts (including accrued interest and hedge adjustments) instead of nominal amounts for own funds calculation. KBC has applied this EBA recommendation as from 30-09-2024. Implementation of this approach increases the volatility in the Tier 2 capital: as at 31-03-2025 it has a 56 million euros positive impact on Tier 2 capital at KBC Group level (compared to 47 million euros on 31-12-2024).
The impact of Basel 4 based on the 31-03-2025 balance sheet is as follows (projections applying a static balance sheet and all other parameters ceteris paribus, without mitigating actions):
| 31-03-2025 | 31-03-2025 | 31-12-2024 | 31-12-2024 | |
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Transitional | Fully loaded | Transitional |
| Total regulatory capital (after profit appropriation) | 22 567 | 22 443 | 22 374 | 21 048 |
| Tier-1 capital | 19 911 | 19 801 | 19 811 | 18 485 |
| Common equity | 18 047 | 17 937 | 17 947 | 16 621 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 22 188 | 21 782 | 21 589 | 18 932 |
| Intangible fixed assets, incl deferred tax impact (-) | - 677 | - 677 | - 743 | - 743 |
| Goodwill on consolidation, incl deferred tax impact (-) | - 1 058 | - 1 058 | - 1 052 | - 1 052 |
| Minority interests | 0 | 0 | 0 | 0 |
| Hedging reserve (cash flow hedges) (-) | 283 | 283 | 508 | 508 |
| Valuation diff. in financial liabilities at fair value - own credit risk (-) | - 29 | - 29 | - 29 | - 29 |
| Value adjustment due to the requirements for prudent valuation (-) | - 34 | - 34 | - 35 | - 35 |
| Dividend payout (-) | - 1 499 | - 1 249 | - 1 249 | 0 |
| Share buyback (part not yet executed) (-) | 0 | 0 | 0 | 0 |
| Coupon of AT1 instruments (-) | - 10 | - 10 | - 27 | - 27 |
| Deduction re. financing provided to shareholders (-) | - 20 | - 20 | - 23 | - 23 |
| Deduction re. Irrevocable payment commitments (-) | - 87 | - 90 | - 90 | - 90 |
| Deduction re NPL backstops (-) | - 197 | - 197 | - 205 | - 205 |
| Deduction re pension plan assets (-) | - 180 | - 180 | - 205 | - 205 |
| IRB provision shortfall (-) | - 278 | - 229 | - 141 | - 66 |
| Deferred tax assets on losses carried forward (-) | - 355 | - 355 | - 353 | - 353 |
| Transitional adjustments to CET1 | 0 | 0 | 0 | 7 |
| Limit on deferred tax assets from timing differences relying on future profitability and significant participations in financial sector entities (-) |
0 | 0 | 0 | 0 |
| Additional going concern capital | 1 864 | 1 864 | 1 864 | 1 864 |
| CRR compliant AT1 instruments | 1 864 | 1 864 | 1 864 | 1 864 |
| Minority interests to be included in additional going concern capital | 0 | 0 | 0 | 0 |
| Tier 2 capital | 2 656 | 2 643 | 2 563 | 2 563 |
| IRB provision excess (+) | 255 | 241 | 167 | 167 |
| Transitional adjustments to T2 | 0 | 0 | 0 | 0 |
| Subordinated liabilities | 2 401 | 2 401 | 2 396 | 2 396 |
| Subordinated loans non-consolidated financial sector entities (-) | 0 | 0 | 0 | 0 |
| Minority interests to be included in tier 2 capital | 0 | 0 | 0 | 0 |
| Total weighted risk volume | 124 789 | 123 005 | 119 945 | 119 950 |
| Banking | 117 878 | 116 094 | 110 082 | 110 087 |
| Insurance | 6 171 | 6 171 | 9 133 | 9 133 |
| Holding activities | 740 | 740 | 734 | 734 |
| Elimination of intercompany transactions | 0 | 0 | - 5 | - 5 |
| Solvency ratios | ||||
| Common equity ratio | 14.46% | 14.58% | 14.96% | 13.86% |
| Tier-1 ratio | 15.96% | 16.10% | 16.52% | 15.41% |
| Total capital ratio | 18.08% | 18.25% | 18.65% | 17.55% |
Note:
• For the composition of the banking RWA, see section 'Solvency banking and insurance activities separately' further in this report.
• As at 31-03-2025, the difference between the fully loaded total own funds (22 567 million euros, interim profit after 50% pay-out re. 2025 is included) and the transitional own funds (22 443 million euros, interim profit after 50% pay-out re. 2025 is not included) is mainly explained by the net result for 1Q2025 (406 million euros under the Danish Compromise method), the 50% pay-out (-250 million euros dividend accrual) and the IRB excess/shortfall (-34 million euros).
| Leverage ratio KBC Group | 31-03-2025 | 31-03-2025 | 31-12-2024 | 31-12-2024 |
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Transitional | Fully loaded | Transitional |
| Tier-1 capital | 19 911 | 19 801 | 19 811 | 18 485 |
| Total exposures | 370 530 | 370 536 | 360 085 | 360 092 |
| Total Assets | 380 313 | 380 313 | 373 048 | 373 048 |
| Deconsolidation KBC Insurance | -33 852 | -33 852 | -33 734 | -33 734 |
| Transitional adjustment | 0 | 0 | 0 | 7 |
| Adjustment for derivatives | - 576 | - 576 | - 885 | - 885 |
| Adjustment for regulatory corrections in determining Basel III Tier-1 capital | -2 756 | -2 750 | -2 681 | -2 681 |
| Adjustment for securities financing transaction exposures | 2 107 | 2 107 | 1 686 | 1 686 |
| Central Bank exposure | 0 | 0 | 0 | 0 |
| Off-balance sheet exposures | 25 293 | 25 293 | 22 651 | 22 651 |
| Leverage ratio | 5.37% | 5.34% | 5.50% | 5.13% |
At the end of March 2025, the fully loaded leverage ratio decreased compared to December 2024, due to higher leverage ratio exposure chiefly as a result of a large increase in reverse repos (for more information see balance sheet in the Consolidated financial statements section).
. . .
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016.
The tables below show the tier-1 and CAD ratios calculated under Basel III (CRR/CRD) for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| Regulatory capital requirements KBC Bank (consolidated) | 31-03-2025 | 31-03-2025 | 31-12-2024 | 31-12-2024 |
|---|---|---|---|---|
| (in millions of EUR) | Fully loaded | Transitional | Fully loaded | Transitional |
| Total regulatory capital, after profit appropriation | 20 522 | 20 319 | 20 296 | 18 981 |
| Tier-1 capital | 17 892 | 17 702 | 17 755 | 16 440 |
| Common equity | 16 028 | 15 838 | 15 891 | 14 576 |
| Parent shareholders' equity | 19 155 | 18 764 | 18 559 | 16 665 |
| Solvency adjustments | -3 128 | -2 926 | -2 668 | -2 088 |
| Additional going concern capital | 1 864 | 1 864 | 1 864 | 1 864 |
| Tier-2 capital | 2 630 | 2 617 | 2 541 | 2 541 |
| Total weighted risk volume | 118 022 | 116 239 | 110 082 | 110 087 |
| Credit risk | 99 269 | 97 986 | 94 213 | 94 218 |
| Market risk | 2 440 | 1 940 | 2 026 | 2 026 |
| Operation risk | 16 313 | 16 313 | 13 843 | 13 843 |
| Common equity ratio | 13.6% | 13.6% | 14.4% | 13.2% |
| Own Funds | 4 551 | 4 392 |
|---|---|---|
| Tier 1 | 4 050 | 3 891 |
| IFRS Parent shareholders equity | 3 612 | 3 331 |
| Dividend payout | - 179 | - 91 |
| Deduction intangible assets and goodwill (after tax) | - 211 | - 207 |
| Valuation differences (after tax) | 583 | 633 |
| Volatility adjustment | 192 | 189 |
| Other | 54 | 37 |
| Tier 2 | 501 | 501 |
| Subordinated liabilities | 501 | 501 |
| Solvency Capital Requirement (SCR) | 2 171 | 2 196 |
| Market risk | 1 474 | 1 533 |
| Non-life | 817 | 821 |
| Life | 1 312 | 1 222 |
| Health | 268 | 321 |
| Counterparty | 138 | 121 |
| Diversification | -1 379 | -1 385 |
| Other | - 459 | - 435 |
| Solvency II ratio | 210% | 200% |
Besides the ECB and NBB, which supervise KBC on a going concern basis, KBC is also subject to requirements set by the Single Resolution Board (SRB). The SRB is developing resolution plans for the major banks in the euro area. The resolution plan for KBC is based on a Single Point of Entry (SPE) approach at the level of KBC Group with 'bail-in' as the primary resolution tool. MREL measures the amount of own funds and eligible liabilities that can be credibly and feasibly bailed-in.
In June 2024, the SRB formally communicated to KBC binding MREL targets (under BRRD2), expressed as a percentage of Risk Weighted Assets (RWA) and Leverage Ratio Exposure Amount (LRE):
Besides a total MREL amount, BRRD2 also requires KBC to maintain a certain part of MREL in subordinated format (i.e. instruments subordinated to liabilities, excluded from bail-in).
The binding subordinated MREL targets are:
At the end of March 2025, the MREL ratio stands at 31.4% as a % of RWA (versus 30.7% as at the end 2024) and at 10.4% as % of LRE (versus 10.2% as at the end of 2024). The increased MREL ratio in % of RWA reflects the higher available MREL (higher CET1 capital explained by retained profit 2024 and new MREL instruments issues) partly offset by increase of RWA. The increase of the MREL ratio in % of LRE is driven mainly higher available MREL, partly offset by increased leverage exposure.
(1) Combined Buffer Requirement (transitional) = Conservation Buffer (2.50%) + O-SII Buffer (1.50%) + Countercyclical Buffer (1.12%) + Systemic Risk Buffer (0.11%) comes on top of the MREL target as a percentage of RWA.
Details on our segments or business units are available in the company presentation.
Note: The ECB approved to apply the IFRS9 transitional arrangements from 2Q 2020, as such the difference between fully loaded and the transitional measures are assigned to Group Centre. In other words, the RWA, allocated capital and the ROAC of the different countries remain based on fully loaded.
| KBC Group | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 | 1Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 1 421 | 1 433 | 1 394 | 1 379 | 1 369 |
| Insurance revenues before reinsurance | 773 | 764 | 740 | 726 | 714 |
| Non-life | 648 | 640 | 631 | 613 | 598 |
| Life | 125 | 124 | 109 | 114 | 116 |
| Dividend income | 9 | 13 | 11 | 26 | 7 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | - 45 | - 74 | - 42 | 3 | - 55 |
| Net fee and commission income | 690 | 700 | 641 | 623 | 614 |
| Net other income | 67 | 27 | 45 | 51 | 58 |
| TOTAL INCOME | 2 915 | 2 863 | 2 787 | 2 809 | 2 708 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 1 498 | - 1 126 | - 1 058 | - 950 | - 1 431 |
| Total Opex without bank and insurance tax | - 1 106 | - 1 201 | - 1 135 | - 1 074 | - 1 063 |
| Total bank and insurance tax | - 539 | - 55 | - 47 | - 2 | - 518 |
| Minus: Opex allocated to insurance service expenses | 148 | 131 | 124 | 126 | 150 |
| Insurance service expenses before reinsurance | - 622 | - 635 | - 688 | - 590 | - 563 |
| Of which Insurance commissions paid | - 102 | - 103 | - 99 | - 92 | - 89 |
| Non-life | - 543 | - 561 | - 615 | - 514 | - 489 |
| of which Non-life - Claim related expenses | - 337 | - 364 | - 427 | - 331 | - 293 |
| Life | - 79 | - 74 | - 72 | - 76 | - 73 |
| Net result from reinsurance contracts held | - 9 | - 4 | 28 | - 24 | - 18 |
| Impairment | - 38 | - 78 | - 69 | - 85 | - 16 |
| on FA at amortised cost and at FVOCI | - 38 | - 50 | - 61 | - 72 | - 16 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 28 | - 7 | - 13 | 0 |
| Share in results of associated companies and joint ventures | 0 | - 1 | 78 | 2 | 0 |
| RESULT BEFORE TAX | 747 | 1 020 | 1 079 | 1 162 | 680 |
| Income tax expense | - 202 | 96 | - 211 | - 237 | - 175 |
| RESULT AFTER TAX | 546 | 1 115 | 868 | 925 | 506 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 546 | 1 116 | 868 | 925 | 506 |
| Banking | 395 | 967 | 774 | 774 | 356 |
| Insurance | 140 | 139 | 104 | 139 | 133 |
| Holding activities | 11 | 10 | - 9 | 13 | 16 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 197 326 | 192 067 | 188 623 | 187 502 | 183 722 |
| of which Mortgage loans (end of period) | 79 429 | 78 059 | 76 926 | 76 236 | 75 311 |
| Customer deposits and debt certificates excl. repos (end of period) | 271 716 | 271 087 | 263 071 | 271 610 | 263 700 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 29 296 | 29 596 | 29 020 | 28 272 | 27 938 |
| Liabilities under investment contracts (IFRS 9) | 15 631 | 15 671 | 15 193 | 14 780 | 14 319 |
| Insurance contract liabilities (IFRS 17) | 13 665 | 13 925 | 13 827 | 13 492 | 13 618 |
| Non-life insurance | 3 247 | 3 186 | 3 186 | 3 029 | 2 984 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 124 789 | 119 945 | 116 817 | 115 635 | 114 101 |
| Required capital, insurance (end of period) | 2 171 | 2 196 | 2 206 | 2 153 | 2 055 |
| Allocated capital (end of period) | 15 076 | 14 297 | 13 965 | 13 783 | 13 517 |
| Return on allocated capital (ROAC, YTD) | 15% | 25% | 22% | 21% | 15% |
| Cost/income ratio without banking and insurance tax (YTD) | 41% | 43% | 43% | 42% | 43% |
| Combined ratio, non-life insurance (YTD) | 86% | 90% | 89% | 87% | 85% |
| Net interest margin, banking (QTD) | 2.05% | 2.08% | 2.08% | 2.10% | 2.08% |
| Business unit Belgium | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 | 1Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 830 | 837 | 828 | 831 | 809 |
| Insurance revenues before reinsurance | 471 | 469 | 447 | 445 | 443 |
| Non-life | 390 | 387 | 379 | 371 | 365 |
| Life | 81 | 83 | 68 | 74 | 78 |
| Dividend income | 9 | 12 | 7 | 24 | 7 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | - 71 | - 113 | - 65 | - 64 | - 101 |
| Net fee and commission income | 454 | 446 | 419 | 409 | 409 |
| Net other income | 61 | 51 | 49 | 46 | 54 |
| TOTAL INCOME | 1 753 | 1 703 | 1 686 | 1 692 | 1 621 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 900 | - 589 | - 563 | - 503 | - 841 |
| Total Opex without bank and insurance tax | - 628 | - 666 | - 634 | - 609 | - 606 |
| Total bank and insurance tax | - 356 | 0 | 0 | 32 | - 317 |
| Minus: Opex allocated to insurance service expenses | 84 | 76 | 71 | 73 | 82 |
| Insurance service expenses before reinsurance | - 383 | - 386 | - 360 | - 363 | - 340 |
| Of which Insurance commissions paid | - 63 | - 63 | - 62 | - 59 | - 57 |
| Non-life | - 330 | - 337 | - 311 | - 311 | - 289 |
| of which Non-life - Claim related expenses | - 224 | - 228 | - 209 | - 210 | - 191 |
| Life | - 53 | - 49 | - 49 | - 53 | - 52 |
| Net result from reinsurance contracts held | - 4 | - 10 | - 20 | - 9 | - 24 |
| Impairment | - 24 | - 58 | - 42 | - 123 | - 37 |
| on FA at amortised cost and at FVOCI | - 24 | - 48 | - 40 | - 122 | - 37 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 11 | - 2 | - 1 | 0 |
| Share in results of associated companies and joint ventures | 1 | 0 | 78 | 1 | 0 |
| RESULT BEFORE TAX | 443 | 660 | 779 | 694 | 380 |
| Income tax expense | - 163 | - 173 | - 182 | - 176 | - 137 |
| RESULT AFTER TAX | 281 | 487 | 598 | 518 | 242 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 281 | 487 | 598 | 519 | 243 |
| Banking | 187 | 391 | 503 | 407 | 143 |
| Insurance | 94 | 96 | 95 | 111 | 99 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 126 204 | 123 887 | 121 832 | 121 459 | 119 331 |
| of which Mortgage loans (end of period) | 46 835 | 46 297 | 45 970 | 45 613 | 45 397 |
| Customer deposits and debt certificates excl. repos (end of period) | 163 206 | 164 483 | 157 465 | 165 002 | 157 665 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 27 573 | 27 862 | 27 266 | 26 530 | 26 213 |
| Liabilities under investment contracts (IFRS 9) | 15 631 | 15 671 | 15 193 | 14 780 | 14 319 |
| Insurance contract liabilities (IFRS 17) | 11 942 | 12 191 | 12 073 | 11 750 | 11 894 |
| Non-life insurance Performance Indicators |
2 424 | 2 371 | 2 361 | 2 298 | 2 282 |
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 71 982 | 67 340 | 65 297 | 63 753 | 63 063 |
| Required capital, insurance (end of period) | 1 849 | 1 868 | 1 906 | 1 801 | 1 785 |
| Allocated capital (end of period) | 9 681 | 9 221 | 9 036 | 8 763 | 8 672 |
| Return on allocated capital (ROAC, YTD) | 12% | 21% | 21% | 18% | 11% |
| Cost/income ratio without banking and insurance tax (YTD) | 39% | 41% | 41% | 40% | 41% |
| Combined ratio, non-life insurance (YTD) | 86% | 88% | 87% | 86% | 86% |
| Net interest margin, banking (QTD) | 1.87% | 1.90% | 1.94% | 1.97% | 1.94% |
| Business unit Czech Republic | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 | 1Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 336 | 335 | 325 | 323 | 315 |
| Insurance revenues before reinsurance | 156 | 153 | 151 | 144 | 138 |
| Non-life | 130 | 126 | 126 | 119 | 114 |
| Life | 26 | 26 | 25 | 25 | 24 |
| Dividend income | 0 | 0 | 0 | 1 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 17 | 28 | 11 | 10 | 22 |
| Net fee and commission income | 94 | 97 | 87 | 84 | 84 |
| Net other income | 2 | 0 | 0 | - 1 | 5 |
| TOTAL INCOME | 605 | 614 | 573 | 561 | 564 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 228 | - 222 | - 207 | - 196 | - 229 |
| Total Opex without bank and insurance tax | - 231 | - 249 | - 234 | - 221 | - 220 |
| Total bank and insurance tax | - 25 | - 1 | - 1 | - 3 | - 35 |
| Minus: Opex allocated to insurance service expenses | 28 | 28 | 29 | 27 | 26 |
| Insurance service expenses before reinsurance | - 115 | - 130 | - 198 | - 104 | - 99 |
| Of which Insurance commissions paid | - 21 | - 21 | - 20 | - 16 | - 17 |
| Non-life | - 100 | - 115 | - 185 | - 91 | - 86 |
| of which Non-life - Claim related expenses | - 58 | - 73 | - 143 | - 53 | - 49 |
| Life | - 14 | - 16 | - 13 | - 12 | - 13 |
| Net result from reinsurance contracts held | - 5 | 10 | 60 | - 6 | - 4 |
| Impairment | - 14 | 11 | - 17 | 41 | - 4 |
| on FA at amortised cost and at FVOCI | - 14 | 13 | - 17 | 41 | - 4 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 2 | 0 | - 1 | 0 |
| Share in results of associated companies and joint ventures | - 1 | - 1 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 243 | 282 | 211 | 297 | 229 |
| Income tax expense | - 36 | - 44 | - 32 | - 52 | - 33 |
| RESULT AFTER TAX | 207 | 238 | 179 | 244 | 197 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 207 | 238 | 179 | 244 | 197 |
| Banking | 176 | 210 | 165 | 213 | 164 |
| Insurance | 32 | 28 | 15 | 31 | 32 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 40 530 | 38 338 | 37 756 | 37 422 | 36 262 |
| of which Mortgage loans (end of period) | 20 480 | 20 028 | 19 738 | 19 685 | 19 283 |
| Customer deposits and debt certificates excl. repos (end of period) | 53 942 | 52 709 | 51 867 | 51 939 | 51 435 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 831 | 835 | 862 | 868 | 891 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 831 | 835 | 862 | 868 | 891 |
| Non-life insurance | 411 | 413 | 422 | 349 | 343 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 21 533 | 18 530 | 18 389 | 18 124 | 17 488 |
| Required capital, insurance (end of period) | 176 | 169 | 166 | 170 | 163 |
| Allocated capital (end of period) | 2 519 | 2 193 | 2 174 | 2 149 | 2 073 |
| Return on allocated capital (ROAC, YTD) | 35% | 40% | 39% | 42% | 38% |
| Cost/income ratio without banking and insurance tax (YTD) | 42% | 43% | 43% | 42% | 42% |
| Combined ratio, non-life insurance (YTD) | 81% | 86% | 87% | 80% | 79% |
| Net interest margin, banking (QTD) | 2.44% | 2.46% | 2.40% | 2.42% | 2.39% |
| Business unit International Markets | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 | 1Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 328 | 328 | 321 | 317 | 324 |
| Insurance revenues before reinsurance | 143 | 139 | 138 | 133 | 130 |
| Non-life | 126 | 123 | 123 | 119 | 116 |
| Life | 18 | 16 | 15 | 15 | 15 |
| Dividend income | 0 | 0 | 1 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 10 | 7 | 8 | 14 | 26 |
| Net fee and commission income | 143 | 158 | 136 | 131 | 122 |
| Net other income | 5 | - 21 | 0 | 9 | 6 |
| TOTAL INCOME | 629 | 610 | 604 | 605 | 608 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 332 | - 264 | - 236 | - 215 | - 326 |
| Total Opex without bank and insurance tax | - 213 | - 236 | - 214 | - 207 | - 200 |
| Total bank and insurance tax | - 155 | - 55 | - 46 | - 32 | - 167 |
| Minus: Opex allocated to insurance service expenses | 35 | 26 | 25 | 25 | 41 |
| Insurance service expenses before reinsurance | - 124 | - 120 | - 127 | - 121 | - 125 |
| Of which Insurance commissions paid | - 18 | - 19 | - 17 | - 17 | - 15 |
| Non-life | - 113 | - 110 | - 117 | - 111 | - 116 |
| of which Non-life - Claim related expenses | - 56 | - 65 | - 73 | - 67 | - 55 |
| Life | - 11 | - 10 | - 9 | - 11 | - 9 |
| Net result from reinsurance contracts held | - 3 | - 2 | 6 | - 3 | 0 |
| Impairment | - 4 | - 15 | - 9 | - 3 | 20 |
| on FA at amortised cost and at FVOCI | - 4 | 0 | - 4 | 9 | 20 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 15 | - 6 | - 11 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 165 | 209 | 239 | 263 | 177 |
| Income tax expense | - 30 | - 34 | - 34 | - 39 | - 30 |
| RESULT AFTER TAX | 135 | 175 | 205 | 224 | 146 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 135 | 175 | 205 | 224 | 146 |
| Banking | 118 | 158 | 187 | 212 | 141 |
| Insurance | 17 | 17 | 18 | 12 | 6 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 30 592 | 29 842 | 29 035 | 28 621 | 28 129 |
| of which Mortgage loans (end of period) | 12 113 | 11 735 | 11 218 | 10 937 | 10 631 |
| Customer deposits and debt certificates excl. repos (end of period) | 32 905 | 32 832 | 32 189 | 31 730 | 31 702 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 892 | 899 | 891 | 875 | 833 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 892 | 899 | 891 | 875 | 833 |
| Non-life insurance | 397 | 382 | 379 | 362 | 345 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 23 699 | 23 757 | 22 758 | 23 382 | 23 082 |
| Required capital, insurance (end of period) | 193 | 188 | 183 | 179 | 171 |
| Allocated capital (end of period) | 2 772 | 2 782 | 2 668 | 2 732 | 2 691 |
| Return on allocated capital (ROAC, YTD) | 19% | 28% | 29% | 27% | 22% |
| Cost/income ratio without banking and insurance tax (YTD) | 37% | 38% | 37% | 36% | 35% |
| Combined ratio, non-life insurance (YTD) | 95% | 96% | 97% | 100% | 102% |
| Net interest margin, banking (QTD) | 3.13% | 3.16% | 3.18% | 3.27% | 3.40% |
Note: The combined ratio, non-life insurance includes a significant windfall tax fully booked in first quarter. Excluding the windfall tax, the combined ratio amounted to 87% in 1Q 2025, 93% in 2024, 92% in 9M 2024 & 1H 2024 and 88% in 1Q 2024.
| Slovakia | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 | 1Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 72 | 70 | 69 | 69 | 67 |
| Insurance revenues before reinsurance | 28 | 28 | 28 | 27 | 26 |
| Non-life | 22 | 22 | 22 | 22 | 21 |
| Life | 6 | 6 | 5 | 5 | 5 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 4 | 0 | - 1 | 2 | 3 |
| Net fee and commission income | 23 | 25 | 21 | 21 | 21 |
| Net other income | 3 | 1 | 0 | 5 | 3 |
| TOTAL INCOME | 130 | 124 | 116 | 125 | 121 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 64 | - 69 | - 69 | - 66 | - 64 |
| Total Opex without bank and insurance tax | - 67 | - 68 | - 66 | - 64 | - 62 |
| Total bank and insurance tax | - 4 | - 8 | - 9 | - 8 | - 9 |
| Minus: Opex allocated to insurance service expenses | 7 | 7 | 7 | 7 | 7 |
| Insurance service expenses before reinsurance | - 25 | - 29 | - 28 | - 32 | - 24 |
| Of which Insurance commissions paid | - 4 | - 4 | - 3 | - 3 | - 3 |
| Non-life | - 21 | - 26 | - 24 | - 28 | - 21 |
| of which Non-life - Claim related expenses | - 13 | - 17 | - 16 | - 21 | - 13 |
| Life | - 4 | - 3 | - 4 | - 4 | - 3 |
| Net result from reinsurance contracts held | - 1 | 1 | 3 | 0 | - 1 |
| Impairment | 2 | 3 | - 3 | 6 | 11 |
| on FA at amortised cost and at FVOCI | 2 | 4 | - 3 | 6 | 11 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 43 | 30 | 20 | 33 | 43 |
| Income tax expense | - 9 | - 4 | - 4 | - 7 | - 9 |
| RESULT AFTER TAX | 34 | 26 | 16 | 27 | 34 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 34 | 26 | 16 | 27 | 34 |
| Banking | 31 | 25 | 13 | 30 | 33 |
| Insurance | 3 | 1 | 2 | - 4 | 1 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 12 195 | 11 887 | 11 672 | 11 667 | 11 625 |
| of which Mortgage loans (end of period) | 6 849 | 6 729 | 6 622 | 6 578 | 6 504 |
| Customer deposits and debt certificates excl. repos (end of period) | 8 995 | 9 360 | 9 228 | 8 961 | 8 830 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 166 | 174 | 173 | 173 | 165 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 166 | 174 | 173 | 173 | 165 |
| Non-life insurance | 77 | 75 | 72 | 68 | 59 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 7 429 | 7 949 | 7 768 | 7 827 | 7 817 |
| Required capital, insurance (end of period) | 34 | 33 | 32 | 32 | 30 |
| Allocated capital (end of period) | 842 | 901 | 880 | 886 | 884 |
| Return on allocated capital (ROAC, YTD) | 16% | 11% | 11% | 14% | 15% |
| Cost/income ratio without banking and insurance tax (YTD) | 54% | 57% | 56% | 54% | 54% |
| Combined ratio, non-life insurance (YTD) | 98% | 112% | 112% | 120% | 107% |
| Hungary | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 | 1Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 144 | 141 | 143 | 138 | 149 |
| Insurance revenues before reinsurance | 55 | 50 | 52 | 50 | 52 |
| Non-life | 49 | 45 | 47 | 45 | 47 |
| Life | 6 | 5 | 5 | 5 | 5 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 6 | 8 | 9 | 12 | 22 |
| Net fee and commission income | 81 | 92 | 75 | 71 | 63 |
| Net other income | 1 | - 28 | - 2 | 3 | 3 |
| TOTAL INCOME | 287 | 263 | 277 | 275 | 289 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 188 | - 124 | - 103 | - 87 | - 179 |
| Total Opex without bank and insurance tax | - 79 | - 87 | - 75 | - 72 | - 69 |
| Total bank and insurance tax | - 128 | - 46 | - 37 | - 24 | - 137 |
| Minus: Opex allocated to insurance service expenses | 20 | 9 | 9 | 9 | 27 |
| Insurance service expenses before reinsurance | - 54 | - 42 | - 53 | - 44 | - 66 |
| Of which Insurance commissions paid | - 3 | - 3 | - 3 | - 4 | - 2 |
| Non-life | - 50 | - 39 | - 50 | - 40 | - 63 |
| of which Non-life - Claim related expenses | - 18 | - 21 | - 31 | - 21 | - 25 |
| Life | - 4 | - 3 | - 3 | - 4 | - 3 |
| Net result from reinsurance contracts held | - 1 | - 1 | 6 | - 2 | 5 |
| Impairment | 0 | - 15 | 1 | - 3 | 11 |
| on FA at amortised cost and at FVOCI | 0 | - 1 | 6 | 8 | 10 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 14 | - 5 | - 11 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 45 | 81 | 127 | 139 | 60 |
| Income tax expense | - 10 | - 17 | - 17 | - 18 | - 10 |
| RESULT AFTER TAX | 35 | 65 | 110 | 121 | 50 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 35 | 65 | 110 | 121 | 50 |
| Banking | 33 | 57 | 105 | 115 | 58 |
| Insurance | 2 | 8 | 5 | 6 | - 8 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 6 996 | 6 857 | 6 860 | 6 773 | 6 640 |
| of which Mortgage loans (end of period) | 2 023 | 1 937 | 1 980 | 1 903 | 1 815 |
| Customer deposits and debt certificates excl. repos (end of period) | 10 100 | 9 607 | 9 587 | 9 536 | 9 577 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 310 | 308 | 316 | 315 | 305 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 310 | 308 | 316 | 315 | 305 |
| Non-life insurance | 126 | 119 | 125 | 119 | 117 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 6 865 | 6 661 | 6 491 | 6 777 | 6 641 |
| Required capital, insurance (end of period) | 67 | 64 | 62 | 62 | 58 |
| Allocated capital (end of period) | 814 | 791 | 771 | 802 | 784 |
| Return on allocated capital (ROAC, YTD) | 17% | 44% | 48% | 43% | 25% |
| Cost/income ratio without banking and insurance tax (YTD) | 29% | 29% | 27% | 26% | 25% |
| Combined ratio, non-life insurance (YTD) | 104% | 100% | 104% | 109% | 124% |
Note: The combined ratio, non-life insurance includes a significant windfall tax fully booked in first quarter. Excluding the windfall tax, the combined ratio amounted to 84% in 1Q 2025, 91% in 2024, 92% in 9M 2024, 90% in 1H 2024 and 89% in 1Q 2024.
| Bulgaria | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 | 1Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 112 | 117 | 110 | 110 | 107 |
| Insurance revenues before reinsurance | 60 | 61 | 59 | 57 | 53 |
| Non-life | 54 | 56 | 54 | 52 | 48 |
| Life | 6 | 5 | 5 | 5 | 5 |
| Dividend income | 0 | 0 | 1 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | - 1 | 0 | - 1 | - 1 | 0 |
| Net fee and commission income | 39 | 41 | 40 | 38 | 37 |
| Net other income | 1 | 6 | 2 | 1 | 0 |
| TOTAL INCOME | 212 | 224 | 211 | 205 | 197 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 81 | - 71 | - 64 | - 62 | - 83 |
| Total Opex without bank and insurance tax | - 67 | - 81 | - 72 | - 71 | - 70 |
| Total bank and insurance tax | - 22 | 0 | 0 | 0 | - 21 |
| Minus: Opex allocated to insurance service expenses | 9 | 10 | 9 | 9 | 8 |
| Insurance service expenses before reinsurance | - 46 | - 49 | - 45 | - 45 | - 35 |
| Of which Insurance commissions paid | - 11 | - 11 | - 10 | - 10 | - 9 |
| Non-life | - 43 | - 46 | - 43 | - 42 | - 32 |
| of which Non-life - Claim related expenses | - 25 | - 27 | - 26 | - 26 | - 17 |
| Life | - 3 | - 3 | - 3 | - 3 | - 3 |
| Net result from reinsurance contracts held | - 2 | - 2 | - 2 | - 1 | - 4 |
| Impairment | - 6 | - 4 | - 7 | - 5 | - 2 |
| on FA at amortised cost and at FVOCI | - 6 | - 3 | - 7 | - 5 | - 2 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | - 1 | - 1 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 77 | 98 | 92 | 91 | 74 |
| Income tax expense | - 11 | - 14 | - 12 | - 14 | - 11 |
| RESULT AFTER TAX | 66 | 85 | 80 | 76 | 63 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 66 | 85 | 80 | 76 | 63 |
| Banking | 54 | 76 | 69 | 67 | 50 |
| Insurance | 12 | 8 | 11 | 9 | 13 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 11 401 | 11 098 | 10 503 | 10 182 | 9 864 |
| of which Mortgage loans (end of period) | 3 241 | 3 068 | 2 616 | 2 456 | 2 312 |
| Customer deposits and debt certificates excl. repos (end of period) | 13 811 | 13 865 | 13 373 | 13 234 | 13 295 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 416 | 417 | 402 | 387 | 364 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 416 | 417 | 402 | 387 | 364 |
| Non-life insurance | 194 | 188 | 182 | 176 | 169 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (Basel III fully loaded, end of period) | 9 405 | 9 148 | 8 499 | 8 778 | 8 623 |
| Required capital, insurance (end of period) | 92 | 91 | 89 | 85 | 83 |
| Allocated capital (end of period) | 1 116 | 1 090 | 1 017 | 1 044 | 1 024 |
| Return on allocated capital (ROAC, YTD) | 24% | 29% | 29% | 27% | 25% |
| Cost/income ratio without banking and insurance tax (YTD) | 37% | 40% | 40% | 40% | 40% |
| Combined ratio, non-life insurance (YTD) | 85% | 86% | 85% | 83% | 79% |
Note: 4Q 2024 includes a reclassification of term loans to mortgage loans (+0.3 billion euros).
| Business unit Group Centre | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 | 1Q 2024 |
| Breakdown P&L | |||||
| Net interest income | - 73 | - 68 | - 80 | - 92 | - 79 |
| Insurance revenues before reinsurance | 3 | 4 | 4 | 4 | 4 |
| Non-life | 3 | 4 | 4 | 4 | 4 |
| Life | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 0 | 0 | 2 | 1 | 0 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
0 | 4 | 4 | 42 | - 1 |
| Net fee and commission income | - 1 | - 1 | - 1 | - 1 | - 1 |
| Net other income | - 1 | - 2 | - 4 | - 3 | - 7 |
| TOTAL INCOME | - 72 | - 63 | - 76 | - 49 | - 85 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 38 | - 50 | - 52 | - 36 | - 36 |
| Total Opex without bank and insurance tax | - 35 | - 51 | - 53 | - 37 | - 37 |
| Total bank and insurance tax | - 4 | 0 | 0 | 0 | 1 |
| Minus: Opex allocated to insurance service expenses | 1 | 1 | 1 | 1 | 1 |
| Insurance service expenses before reinsurance | 0 | 1 | - 2 | - 1 | 1 |
| Of which Insurance commissions paid | 0 | 0 | 0 | 0 | 0 |
| Non-life | 0 | 1 | - 2 | - 1 | 1 |
| of which Non-life - Claim related expenses | 1 | 2 | - 2 | - 1 | 2 |
| Life | 0 | 0 | 0 | 0 | 0 |
| Net result from reinsurance contracts held | 3 | - 3 | - 18 | - 6 | 10 |
| Impairment | 3 | - 16 | - 1 | 1 | 4 |
| on FA at amortised cost and at FVOCI | 3 | - 15 | - 1 | 1 | 4 |
| other | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | - 104 | - 131 | - 150 | - 92 | - 105 |
| Income tax expense | 27 | 346 | 36 | 30 | 26 |
| RESULT AFTER TAX | - 77 | 215 | - 114 | - 61 | - 80 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | - 77 | 215 | - 114 | - 61 | - 80 |
| Banking | - 86 | 207 | - 81 | - 59 | - 92 |
| Insurance | - 2 | - 2 | - 24 | - 16 | - 4 |
| Holding activities | 11 | 10 | - 9 | 13 | 16 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 0 | 0 | 0 | 0 | 0 |
| of which Mortgage loans (end of period) | 0 | 0 | 0 | 0 | 0 |
| Customer deposits and debt certificates excl. repos (end of period) | 21 662 | 21 063 | 21 550 | 22 938 | 22 898 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 1 404 | 1 184 | 1 241 | 1 243 | 1 335 |
| Risk-weighted assets, insurance (end of period, Basel III fully loaded) | 6 171 | 9 133 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period) | - 48 | - 28 | - 48 | 2 | - 65 |
| Allocated capital (end of period) | 105 | 101 | 87 | 138 | 81 |
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) |
'Consolidated income statement' | 546 | 3 415 | 506 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) |
'Consolidated statement of changes in equity' | - 23 | - 84 | - 25 |
| / | ||||
| Average number of ordinary shares less treasury shares (in millions) in the period (C) |
Note 5.10 | 397 | 400 | 406 |
| or | ||||
| Average number of ordinary shares plus dilutive options less treasury shares in the period (D) |
397 | 400 | 406 | |
| Basic = (A-B) / (C) (in EUR) | 1.32 | 8.33 | 1.18 | |
| Diluted = (A-B) / (D) (in EUR) | 1.32 | 8.33 | 1.18 | |
Gives insight into the technical profitability of the short-term non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio is defined net of reinsurance.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Non-life PAA – Claims and claim related costs net of reinsurance (A) |
Note 3.6, component of 'Insurance revenues before reinsurance' & of 'Net result from reinsurance contracts held' |
340 | 1 362 | 309 |
| + | ||||
| Costs other than claims and commissions (B) | Note 3.6, component of 'Insurance Service Expenses' & of 'Non-directly attributable income and expenses' & of 'Net result from reinsurance contracts held' |
189 | 729 | 173 |
| / | ||||
| Non-life PAA - Net earned expected premiums received (C) | Note 3.6, component of 'Insurance revenues before reinsurance' & of 'Net result from reinsurance contracts held' |
613 | 2 331 | 565 |
| = (A+B) / (C) | 86.3% | 89.7% | 85.3% |
A risk-weighted measure of the group's solvency based on common equity tier-1 capital (the ratios given here are based on the Danish compromise). Changes to the capital rules are gradually being implemented to allow banks to build up the necessary capital buffers. The capital position of a bank, when account is taken of the transition period, is referred to as the 'transitional' view. The capital position based on full application of all the rules – as would be the case after this transition period – is referred to as 'fully loaded'.
A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an impression of the relative cost efficiency (costs relative to income without banking and insurance tax, but including insurance commissions paid) of the group.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Cost/income ratio | ||||
| Total Opex without bank and insurance tax (A) | Consolidated income statement | 1 106 | 4 474 | 1 063 |
| + | ||||
| Insurance commissions paid (B) | Note 3.6, component of 'Insurance Service Expenses' |
102 | 383 | 89 |
| / | ||||
| Total income (C) | Consolidated income statement | 2 915 | 11 167 | 2 708 |
| =(A+B) / (C) | 41.5% | 43.5% | 42.5% |
Where relevant, we also exclude the exceptional and/or non-operating items when calculating the cost/income ratio. This calculation aims to give a better idea of the relative cost efficiency of the pure business activities. The adjustments include: MTM ALM derivatives (fully excluded) and one-off items. The Cost/Income ratio adjusted for specific items is 46% in 1Q2025 (versus 47% in 2024).
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. The numerator and denominator in the formula relate to all impaired loans, but may be limited to impaired loans that are more than 90 days past due (the figures for that particular calculation are given in the 'Credit risk' section.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Stage 3 impairment on loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
1 977 | 1 979 | 1 915 |
| / | ||||
| Outstanding impaired loans (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 126 | 4 171 | 4 299 |
| = (A) / (B) | 47.9% | 47.4% | 44.5% |
Gives an idea of loan impairment charges recognised in the income statement for a specific period, relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Net changes in impairment for credit risks (A) |
'Consolidated income statement': component of 'Impairment' |
42 | 207 | 22 |
| / | ||||
| Average outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
213 194 | 206 928 | 202 590 |
| = (A) (annualised) / (B) | 0.08% | 0.10% | 0.04% | |
| *based on YTD view |
Note: a negative % is a release
In 1Q25, the credit cost ratio without the outstanding ECL for geopolitical and macroeconomic uncertainties, amounts to 0.16% (versus 0.16% in 2024).
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12. Where appropriate, the numerator in the formula may be limited to impaired loans that are more than 90 days past due (PD 11 + PD 12). Relevant figures for that calculation are given in the 'Credit Risk' section.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Amount outstanding of impaired loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 126 | 4 171 | 4 299 |
| / | ||||
| Total outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview in the 'Credit risk' section |
215 486 | 210 903 | 202 226 |
| = (A) / (B) | 1.9% | 2.0% | 2.1% |
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio. A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period. It is the average of 12 end-of-month LCR figures.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Stock of high-quality liquid assets (A) | Based on the European Commission's Delegated Act on LCR and the European Banking Authority's guidelines for LCR disclosure |
98 995 | 100 631 | 102 401 |
| / | ||||
| Total net cash outflows over the next 30 calendar days (B) |
63 209 | 63 588 | 63 370 | |
| = (A) / (B) | 157% | 158% | 162% |
KBCs large stock of high-quality liquid assets (approximately 99 billion euros in 1Q25), which consist of cash and bonds which can be repoed in the private market and at the central banks. Note that the 99 billion euros consist of:
• 37 billion euros (or 37%) 'Cash & Central Bank receivables' (= liquidity that could at all times be used instantaneously to cover outflows)
• 62 billion euros (or 62%) 'LCR eligible bonds' which are reported at fair value at all times, independent of IFRS classification
Gives an idea of the magnitude of (what are mainly traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Loans and advances to customers (A) | Note 4.1, component of 'Loans and advances to customers' |
197 326 | 192 067 | 183 722 |
| + | ||||
| Reverse repos (not with Central Banks) (B) | Note 4.1, component of 'Reverse repos with credit institutions' |
1 126 | 424 | 588 |
| + | ||||
| Debt instruments issued by corporates and by credit institutions (not with Central Banks) (banking) (C) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions' |
5 559 | 5 690 | 6 606 |
| + | ||||
| Other exposures to credit institutions (D) | 3 506 | 3 207 | 3 520 | |
| + | ||||
| Financial guarantees granted to clients and other commitments (E) |
Note 6.1, component of 'Financial guarantees given' |
10 767 | 10 476 | 9 941 |
| + | ||||
| Impairment on loans (F) | Note 4.2, component of 'Impairment' |
2 416 | 2 455 | 2 443 |
| + | ||||
| Insurance entities (G) | Note 4.1, component of 'Loans and advances to customers' |
- 1 817 | - 1 847 | - 1 921 |
| + | ||||
| Non-loan-related receivables (H) | - 710 | - 499 | - 517 | |
| + | ||||
| Other (I) | Component of Note 4.1 | - 2 687 | - 1 071 | - 2 155 |
| Gross Carrying amount = (A)+(B)+(C)+(D)+(E)+(F)+(G)+(H)+(I) |
215 486 | 210 903 | 202 226 |
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Net interest income of the banking activities (A) | 'Consolidated income statement': component of 'Net interest income' |
1 292 | 5 063 | 1 238 |
| / | ||||
| Average interest-bearing assets of the banking activities (B) | 'Consolidated balance sheet': component of 'Total assets' |
252 054 | 238 600 | 235 195 |
| = (A) (annualised x360/number of calendar days) / (B) | 2.05% | 2.09% | 2.08% |
The net interest margin is the net interest income of the banking activities, excluding dealing rooms and the net interest impact of ALM FX swaps and repos.
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Available amount of stable funding (A) | Regulation (EU) 2019/876 dd. 20-05-2019 | 226 454 | 221 939 | 212 326 |
| / | ||||
| Required amount of stable funding (B) | 161 959 | 159 835 | 152 858 | |
| = (A) / (B) | 140% | 139% | 139% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or number) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 23 327 | 22 447 | 22 166 |
| / | ||||
| Number of ordinary shares less treasury shares (at period-end) (B) |
Note 5.10 | 397 | 397 | 403 |
| = (A) / (B) (in EUR) | 58.82 | 56.60 | 54.94 |
KBC Group launched a share buyback program for the purpose of distributing the surplus capital from 11th August 2023 until 31st July 2024, for a maximum amount of 1.3 billion euros. At the end of September 2024, the total number of shares entitled to dividend reduced with 20 980 823 shares.
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| BELGIUM BUSINESS UNIT Result after tax (including minority interests) Note 2.2: Results by segment |
281 | 1 846 | |
|---|---|---|---|
| of the business unit (A) | 243 | ||
| / | |||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under CRR/CRD) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
9 438 | 8 832 | 8 570 |
| = (A) annualised / (B) | 11.9% | 20.9% | 11.3% |
| CZECH REPUBLIC BUSINESS UNIT | |||
| Result after tax (including minority interests) of the business Note 2.2: Results by segment unit (A) |
207 | 858 | 197 |
| / | |||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under CRR/CRD) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 352 | 2 133 | 2 075 |
| = (A) annualised / (B) | 35.3% | 40.3% | 38.0% |
| INTERNATIONAL MARKETS BUSINESS UNIT | |||
| Result after tax (including minority interests) of the business Note 2.2: Results by segment unit (A) |
135 | 751 | 146 |
| / | |||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (under CRR/CRD) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 772 | 2 710 | 2 684 |
| = (A) annualised / (B) | 19.5% | 27.7% | 21.8% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) |
'Consolidated income statement' | 546 | 3 415 | 506 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) |
'Consolidated statement of changes in equity' | - 23 | - 84 | - 25 |
| / | ||||
| Average parent shareholders' equity (C) | 'Consolidated statement of changes in equity' | 22 887 | 22 228 | 22 088 |
| = (A-B) (annualised) / (C) | 9.1% | 15.0% | 8.7% |
In 1Q 2025, the return on equity amounts to 15% when including evenly spreading of the bank taxes throughout the year and excluding one-offs.
Total sales of life insurance compromise new business of guaranteed interest contracts, unit-linked investment contracts and hybrid contracts.
| Calculation (in millions of EUR or %) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Guaranteed Interest products | 333 | 1 219 | 261 | |
| + | ||||
| Unit-Linked products | 615 | 1 490 | 471 | |
| + | ||||
| Hybrid products | 64 | 197 | 33 | |
| Total sales Life (A)+ (B) + (C) | 1 013 | 2 906 | 765 |
Measures the solvency of the insurance business, as calculated under Solvency II.
A detailed calculation can be found under 'Solvency banking and insurance activities separately' section.
Total assets under management (AuM) consist of direct client money (Assets under Distribution towards retail, private banking and institutional clients), KBC Group assets (incl. pension fund), fund-of-funds assets and investment advice. Total AuM comprise assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence determine a large part of any change in this income line.
| Calculation (in billions of EUR or quantity) | Reference | 1Q 2025 | 2024 | 1Q 2024 |
|---|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 242 | 245 | 230 |
| + | ||||
| Czech Republic Business Unit (B) | 20 | 19 | 18 | |
| + | ||||
| International Markets Business Unit (C) | 11 | 11 | 10 | |
| A)+(B)+(C) | 273 | 276 | 258 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.